
[
  
 {"id": "rn-001", "scope": ["RN"], "name": { "generic": "Quinidine", "brand": ["Quinaglute"] }, "class": "Sodium Channel Blocker - Class IA antidysrhythmic", "mechanism": "Blocks sodium channels in the cells of the cardiac conduction system", "indications": ["Acute treatment of ventricular cardiac arrhythmias"], "contraindications": ["Baseline prolonged QT interval, Hypersensitivity; Severe sinoatrial node dysfunction, aortic stenosis, or intraventricular blocks"], "interactions": ["Digoxin (toxicity); Beta-adrenergic blockers"], "education": ["Report excessive diarrhea"] },
{"id": "rn-002", "scope": ["RN"], "name": { "generic": "Procainamide", "brand": ["Procan"] }, "class": "Sodium Channel Blocker - Class IA antidysrhythmic", "mechanism": "Blocks sodium channels in the cells of the cardiac conduction system", "indications": ["Acute treatment of ventricular cardiac arrhythmias"], "contraindications": ["Baseline prolonged QT interval, systemic lupus erythematosus, hypersensitivity; Severe sinoatrial node dysfunction, aortic stenosis, or intraventricular blocks"], "interactions": ["Digoxin (toxicity); Beta-adrenergic blockers"], "education": ["Report hypotension, signs of lupus-like syndrome, or unusual bruising/bleeding"] }, 
{"id":"rn-003","scope":["RN"],"name":{"generic":"Lidocaine","brand":["Xylocaine"]},"class":"Sodium Channel Blocker - Class IB antidysrhythmic","mechanism":"Blocks sodium channels in the cells of the cardiac conduction system","indications":["Acute treatment of ventricular cardiac arrhythmias","Local and regional anesthesia"],"contraindications":["Wolff-Parkinson-White syndrome","Hypersensitivity","Severe sinoatrial node dysfunction, aortic stenosis, or intraventricular blocks"],"interactions":["Digoxin (toxicity)","Beta-adrenergic blockers"],"education":["Central nervous system toxicity"]},
{"id":"rn-004","scope":["RN"],"name":{"generic":"Mexiletine","brand":["Mexitil"]},"class":"Sodium Channel Blocker - Class IB antidysrhythmic","mechanism":"Blocks sodium channels in the cells of the cardiac conduction system","indications":["Acute treatment of ventricular cardiac arrhythmias"],"contraindications":["Hypersensitivity","Severe sinoatrial node dysfunction, aortic stenosis, or intraventricular blocks"],"interactions":["Digoxin (toxicity)","Beta-adrenergic blockers"],"education":["Report signs and symptoms of hepatic toxicity"]},
{"id":"rn-005","scope":["RN"],"name":{"generic":"Flecainide","brand":["Tambocor"]},"class":"Sodium Channel Blocker - Class IC antidysrhythmic","mechanism":"Blocks sodium channels in the cells of the cardiac conduction system","indications":["Acute treatment of ventricular cardiac arrhythmias"],"contraindications":["Structural heart disease","Hypersensitivity","Severe sinoatrial node dysfunction, aortic stenosis, or intraventricular blocks"],"interactions":["Digoxin (toxicity)","Beta-adrenergic blockers"],"education":["Risk of 1:1 AV conduction in atrial fibrillation or flutter"]},
{"id":"rn-006","scope":["RN"],"name":{"generic":"Propafenone","brand":["Rhythmol SR"]},"class":"Sodium Channel Blocker - Class IC antidysrhythmic","mechanism":"Blocks sodium channels in the cells of the cardiac conduction system","indications":["Acute treatment of ventricular cardiac arrhythmias"],"contraindications":["Structural heart disease","Hypersensitivity","Severe sinoatrial node dysfunction, aortic stenosis, or intraventricular blocks"],"interactions":["Digoxin (toxicity)","Beta-adrenergic blockers"],"education":["Report signs of infection due to agranulocytosis"]},
{"id":"rn-007","scope":["RN"],"name":{"generic":"Esmolol","brand":["Brevibloc"]},"class":"Beta-adrenergic blocker - Class II antidysrhythmic","mechanism":"Acts as a beta-1 receptor antagonist in cardiac tissue, slowing pacing from the sinoatrial node and conduction through the atrioventricular node","indications":["Short-term treatment of sinus tachycardia","Supraventricular tachycardia","Atrial fibrillation/flutter","Intraoperative and postoperative tachycardia and hypertension"],"contraindications":["Sinus bradycardia","Heart blocks","Cardiogenic shock","Overt cardiac failure","Sick sinus syndrome","Severe peripheral arterial circulatory disorders","Acute myocardial infarction","Hypotension"],"interactions":["Reserpine","Digoxin","Calcium channel blockers","CYP2D6 inhibitors","Alpha-adrenergic blockers","Ergot alkaloids"],"education":["Change positions slowly to avoid orthostatic hypotension","Do not abruptly stop medication"] },
{"id":"rn-008","scope":["RN"],"name":{"generic":"Metoprolol","brand":["Lopressor","Toprol XL"]},"class":"Beta-adrenergic blocker - Class II antidysrhythmic","mechanism":"Acts as a beta-1 receptor antagonist in cardiac tissue, slowing pacing from the sinoatrial node and conduction through the atrioventricular node","indications":["Rate control of atrial fibrillation/flutter","Angina","Heart failure","Hypertension","Myocardial infarction"],"contraindications":["Sinus bradycardia","Heart blocks","Cardiogenic shock","Overt cardiac failure","Sick sinus syndrome","Severe peripheral arterial circulatory disorders","Acute myocardial infarction","Hypotension"],"interactions":["Reserpine","Digoxin","Calcium channel blockers","CYP2D6 inhibitors","Alpha-adrenergic blockers","Ergot alkaloids"],"education":["Change positions slowly to avoid orthostatic hypotension","Do not abruptly stop medication"] },
{"id":"rn-009","scope":["RN"],"name":{"generic":"Atenolol","brand":["Tenormin"]},"class":"Beta-adrenergic blocker - Class II antidysrhythmic","mechanism":"Acts as a beta-1 receptor antagonist in cardiac tissue, slowing pacing from the sinoatrial node and conduction through the atrioventricular node","indications":["Rate control of atrial fibrillation/flutter","Angina","Heart failure","Hypertension","Myocardial infarction"],"contraindications":["Sinus bradycardia","Heart blocks","Cardiogenic shock","Overt cardiac failure","Sick sinus syndrome","Severe peripheral arterial circulatory disorders","Acute myocardial infarction","Hypotension"],"interactions":["Reserpine","Digoxin","Calcium channel blockers","CYP2D6 inhibitors","Alpha-adrenergic blockers","Ergot alkaloids"],"education":["Change positions slowly to avoid orthostatic hypotension","Do not abruptly stop medication"] },
{"id":"rn-010","scope":["RN"],"name":{"generic":"Propranolol","brand":["Inderal"]},"class":"Beta-adrenergic blocker - Class II antidysrhythmic","mechanism":"Acts as a beta-1 receptor antagonist in cardiac tissue, slowing pacing from the sinoatrial node and conduction through the atrioventricular node","indications":["Rate control of atrial fibrillation/flutter","Angina","Heart failure","Hypertension","Myocardial infarction"],"contraindications":["Sinus bradycardia","Heart blocks","Cardiogenic shock","Overt cardiac failure","Sick sinus syndrome","Severe peripheral arterial circulatory disorders","Acute myocardial infarction","Hypotension"],"interactions":["Reserpine","Digoxin","Calcium channel blockers","CYP2D6 inhibitors","Alpha-adrenergic blockers","Ergot alkaloids"],"education":["Change positions slowly to avoid orthostatic hypotension","Do not abruptly stop medication"] },
{"id":"rn-011","scope":["RN"],"name":{"generic":"Bisoprolol","brand":["Zebeta"]},"class":"Beta-adrenergic blocker - Class II antidysrhythmic","mechanism":"Acts as a beta-1 receptor antagonist in cardiac tissue, slowing pacing from the sinoatrial node and conduction through the atrioventricular node","indications":["Rate control of atrial fibrillation/flutter","Angina","Heart failure","Hypertension","Myocardial infarction"],"contraindications":["Sinus bradycardia","Heart blocks","Cardiogenic shock","Overt cardiac failure","Sick sinus syndrome","Severe peripheral arterial circulatory disorders","Acute myocardial infarction","Hypotension"],"interactions":["Reserpine","Digoxin","Calcium channel blockers","CYP2D6 inhibitors","Alpha-adrenergic blockers","Ergot alkaloids"],"education":["Change positions slowly to avoid orthostatic hypotension","Do not abruptly stop medication"] },
{"id": "rn-012", "scope": ["RN"], "name": { "generic": "Amiodarone", "brand": ["Pacerone"] }, "class": "Potassium channel blocker - Class III antidysrhythmic", "mechanism": "Blocks the potassium channels responsible for repolarization of the cell, leading to a prolonged action potential and prolonged refractoriness", "indications": ["Atrial fibrillation and atrial flutter"], "contraindications": ["Hypersensitivity", "Baseline QTc greater than 440 msec", "Severe renal impairment (creatinine clearance less than 20 mL/min)"], "interactions": ["Digoxin", "Warfarin", "Statins", "potassium-depleting diuretics", "drugs that prolong the QT interval"], "education": ["Symptoms of torsade de pointes", "symptoms of hyperthyroidism", "vision changes", "avoid grapefruits"] },
{"id": "rn-013", "scope": ["RN"], "name": { "generic": "Dronedarone", "brand": ["Multaq"] }, "class": "Potassium channel blocker - Class III antidysrhythmic", "mechanism": "Blocks the potassium channels responsible for repolarization of the cell, leading to a prolonged action potential and prolonged refractoriness", "indications": ["Atrial fibrillation and atrial flutter"], "contraindications": ["Hypersensitivity", "Baseline QTc greater than 440 msec", "Severe renal impairment (creatinine clearance less than 20 mL/min)"], "interactions": ["Digoxin", "calcium channel blockers", "statins"], "education": ["Symptoms of torsade de pointes", "symptoms of hyperthyroidism", "vision changes", "avoid grapefruits"] },
{"id": "rn-014", "scope": ["RN"], "name": { "generic": "Dofetilide", "brand": ["Tikosyn"] }, "class": "Potassium channel blocker - Class III antidysrhythmic", "mechanism": "Blocks the potassium channels responsible for repolarization of the cell, leading to a prolonged action potential and prolonged refractoriness", "indications": ["Atrial fibrillation and atrial flutter"], "contraindications": ["Hypersensitivity", "Baseline QTc greater than 440 msec", "Severe renal impairment (creatinine clearance less than 20 mL/min)"], "interactions": ["Potassium-depleting diuretics", "drugs that prolong the QT interval"], "education": ["Symptoms of torsade de pointes", "symptoms of hyperthyroidism", "vision changes", "avoid grapefruits"] },
{"id": "rn-015", "scope": ["RN"], "name": { "generic": "Ibutilide", "brand": ["Corvert"] }, "class": "Potassium channel blocker - Class III antidysrhythmic", "mechanism": "Blocks the potassium channels responsible for repolarization of the cell, leading to a prolonged action potential and prolonged refractoriness", "indications": ["Atrial fibrillation and atrial flutter"], "contraindications": ["Hypersensitivity", "Baseline QTc greater than 440 msec", "Severe renal impairment (creatinine clearance less than 20 mL/min)"], "interactions": ["Potassium-depleting diuretics", "drugs that prolong the QT interval"], "education": ["Symptoms of torsade de pointes", "symptoms of hyperthyroidism", "vision changes", "avoid grapefruits"] },
{"id": "rn-016", "scope": ["RN"], "name": { "generic": "Sotalol", "brand": ["Betapace"] }, "class": "Potassium channel blocker - Class III antidysrhythmic", "mechanism": "Blocks the potassium channels responsible for repolarization of the cell, leading to a prolonged action potential and prolonged refractoriness", "indications": ["Atrial fibrillation and atrial flutter"], "contraindications": ["Hypersensitivity", "Baseline QTc greater than 440 msec", "Severe renal impairment (creatinine clearance less than 20 mL/min)"], "interactions": ["Potassium-depleting diuretics", "drugs that prolong the QT interval"], "education": ["Symptoms of torsade de pointes", "symptoms of hyperthyroidism", "vision changes", "avoid grapefruits"] },
{"id": "rn-017", "scope": ["RN"], "name": { "generic": "Diltiazem", "brand": ["Cardizem"] }, "class": "Calcium Channel Blockers - Class IV antidysrhythmic", "mechanism": "Inhibits the calcium channel in cardiac tissue and blood vessels, leading to decreased conduction through the atrioventricular node and vasodilation", "indications": ["Angina", "Hypertension", "Atrial fibrillation/flutter"], "contraindications": ["Hypersensitivity", "Sick sinus syndrome (unless client has ventricular pacemaker)", "Hypotension", "Myocardial infarction", "Pulmonary congestion"], "interactions": ["Substrates or inhibitors of CYP3A4", "Beta-adrenergic blockers", "Benzodiazepines", "Clonidine", "Digoxin", "Statins"], "education": ["Symptoms of dysrhythmia", "Avoid grapefruit and alcohol"] },
{"id": "rn-018", "scope": ["RN"], "name": { "generic": "Verapamil", "brand": ["Calan SR"] }, "class": "Calcium Channel Blockers - Class IV antidysrhythmic", "mechanism": "Inhibits the calcium channel in cardiac tissue and blood vessels, leading to decreased conduction through the atrioventricular node and vasodilation", "indications": ["Angina", "Hypertension", "Atrial fibrillation/flutter"], "contraindications": ["Hypersensitivity", "Sick sinus syndrome (unless client has ventricular pacemaker)", "Hypotension", "Myocardial infarction", "Pulmonary congestion"], "interactions": ["Substrates or inhibitors of CYP3A4", "Beta-adrenergic blockers", "Benzodiazepines", "Clonidine", "Digoxin", "Statins"], "education": ["Symptoms of dysrhythmia", "Avoid grapefruit and alcohol"] },
{"id": "rn-019", "scope": ["RN"], "name": { "generic": "Atropine", "brand": ["AtroPen"] }, "class": "Antiarrhythmic - Class V, Anticholinergic", "mechanism": "Acetylcholine receptor antagonist, thus decreasing parasympathetic or vagal regulation of the heart rate", "indications": ["Symptomatic bradycardia"], "contraindications": ["Ventricular fibrillation"], "interactions": ["Potassium-sparing diuretics", "calcium", "amiodarone"], "education": ["Anticholinergic adverse effects"] },
{"id":"rn-020","scope":["RN"],"name":{"generic":"Digoxin","brand":["Lanoxin"]},"class":"Antiarrhythmic - Class V / Cardiac glycoside","mechanism":"Inhibits the sodium-potassium ATPase pump, increasing intracellular calcium to strengthen myocardial contraction; enhances parasympathetic activity, slowing heart rate","indications":["Atrial fibrillation","Atrial flutter","Heart failure with persistent symptoms despite optimal therapy"],"contraindications":["Acute myocardial infarction","Wolff–Parkinson–White syndrome","Ventricular fibrillation","Hypokalemia","Hypomagnesemia"],"interactions":["Quinidine","Calcium channel blockers","NSAIDs","Amiodarone","Beta blockers","Diuretics"],"education":["Monitor serum digoxin levels (therapeutic: 0.5–2.0 ng/mL); assess apical pulse before administration; report signs of toxicity such as nausea, vomiting, visual changes, or arrhythmias."]},
{"id": "rn-021", "scope": ["RN"], "name": { "generic": "Adenosine", "brand": ["Adenocard"] }, "class": "Antiarrhythmic - Class V", "mechanism": "Enhancing potassium efflux and suppressing calcium influx into the cells of the AV node", "indications": ["Paroxysmal supraventricular tachycardia"], "contraindications": ["Second- or third-degree AV block"], "interactions": ["Potassium-sparing diuretics", "calcium", "amiodarone"], "education": ["Asystole - sensation of heart stopping"] },
{"id": "rn-022", "scope": ["RN"], "name": { "generic": "Lactated Ringer's", "brand": ["LR"] }, "class": "Crystalloid - Isotonic", "mechanism": "Osmotic equilibrium, water does not enter or leave the cells", "indications": ["Rehydration"], "contraindications": ["Fluid overload", "Increased intracranial pressure"], "interactions": [], "education": [] },
{"id": "rn-023", "scope": ["RN"], "name": { "generic": "Normal Saline", "brand": ["NS"] }, "class": "Crystalloid - Isotonic", "mechanism": "Osmotic equilibrium, water does not enter or leave the cells", "indications": ["Rehydration", "Sodium repletion"], "contraindications": ["Fluid overload", "Increased intracranial pressure"], "interactions": [], "education": [] },
{"id": "rn-024", "scope": ["RN"], "name": { "generic": "5% dextrose in water", "brand": ["D5W"] }, "class": "Crystalloid - Isotonic", "mechanism": "Osmotic equilibrium, water does not enter or leave the cells", "indications": ["Rehydration", "Dextrose supplies calories"], "contraindications": ["Fluid overload", "Increased intracranial pressure"], "interactions": [], "education": [] },
{"id": "rn-025", "scope": ["RN"], "name": { "generic": "0.45% Normal saline", "brand": ["1/2 NS"] }, "class": "Crystalloid - Hypotonic", "mechanism": "Water moves into the cell or ICF compartment", "indications": ["Intracellular fluid volume deficit conditions"], "contraindications": ["Increased intracranial pressure"], "interactions": [], "education": [] },
{"id": "rn-026", "scope": ["RN"], "name": { "generic": "10% Dextrose in water", "brand": ["D10W"] }, "class": "Crystalloid - Hypertonic", "mechanism": "Pulls water from the interstitial space into the ECF causing cell shrinkage", "indications": ["Hyponatremia", "Cerebral edema", "Increased intracranial pressure"], "contraindications": ["Hypervolemia", "Pulmonary edema"], "interactions": [], "education": [] },
{"id": "rn-027", "scope": ["RN"], "name": { "generic": "Albumin", "brand": ["Albumin 5%", "Albumin 25%"] }, "class": "Colloid", "mechanism": "Solutions increase the colloidal oncotic pressure, drawing fluid from interstitial space into plasma", "indications": ["Volume loss"], "contraindications": ["Heart failure", "Anemia"], "interactions": [], "education": [] },
{"id": "rn-028", "scope": ["RN"], "name": { "generic": "Pyridostigmine bromide", "brand": ["Mestinon"] }, "class": "Acetylcholinesterase inhibitor", "mechanism": "Causes reversible inhibition of AChE within the synapse, allowing more ACh to bind to cholinergic receptors and prolonging its effects", "indications": ["Management of MG symptoms", "Reversal of competitive (nondepolarizing) neuromuscular blockade", "Prevention/treatment of urinary retention in postoperative clients"], "contraindications": ["Mechanical obstruction of the intestine or urinary tract"], "interactions": ["Succinylcholine", "Atropine"], "education": ["Signs of therapeutic failure and toxicity", "Change positions slowly"] },
{"id": "rn-029", "scope": ["RN"], "name": { "generic": "Neostigmine", "brand": ["Bloxiverz"] }, "class": "Acetylcholinesterase inhibitor", "mechanism": "Causes reversible inhibition of AChE within the synapse, allowing more ACh to bind to cholinergic receptors and prolonging its effects", "indications": ["Management of MG symptoms", "Reversal of competitive (nondepolarizing) neuromuscular blockade", "Prevention/treatment of urinary retention in postoperative clients"], "contraindications": ["Mechanical obstruction of the intestine or urinary tract"], "interactions": ["Succinylcholine", "Atropine"], "education": ["Signs of therapeutic failure and toxicity", "Change positions slowly"] },
{"id": "rn-030", "scope": ["RN"], "name": { "generic": "Donepezil", "brand": ["Aricept"] }, "class": "Acetylcholinesterase inhibitor", "mechanism": "Causes reversible inhibition of AChE", "indications": ["Mild to severe Alzheimer’s disease", "To treat overdoses of atropine and other centrally acting anticholinergic drugs"], "contraindications": ["Active peptic ulcer disease", "Active GI bleeding", "Urinary or intestinal obstruction", "Hypersensitivity"], "interactions": ["Anticholinergic agents", "NSAIDs", "Beta blockers", "Digoxin", "TCAs"], "education": ["Takes 15 days for drug to reach steady state"] },
{"id": "rn-031", "scope": ["RN"], "name": { "generic": "Donepezil transdermal", "brand": ["Adlarity"] }, "class": "Acetylcholinesterase inhibitor", "mechanism": "Causes reversible inhibition of AChE", "indications": ["Mild to severe Alzheimer’s disease"], "contraindications": ["Active peptic ulcer disease", "Active GI bleeding", "Urinary or intestinal obstruction", "Hypersensitivity"], "interactions": ["Anticholinergic agents", "NSAIDs", "Beta blockers", "Digoxin", "TCAs"], "education": ["Takes 15 days for drug to reach steady state"] },
{"id": "rn-032", "scope": ["RN"], "name": { "generic": "Galantamine", "brand": ["Razadyne"] }, "class": "Acetylcholinesterase inhibitor", "mechanism": "Causes reversible inhibition of AChE", "indications": ["Mild to severe Alzheimer’s disease"], "contraindications": ["Active peptic ulcer disease", "Active GI bleeding", "Urinary or intestinal obstruction", "Hypersensitivity"], "interactions": ["Anticholinergic agents", "NSAIDs", "Beta blockers", "Digoxin", "TCAs"], "education": ["Stevens-Johnson Syndrome"] },
{"id": "rn-033", "scope": ["RN"], "name": { "generic": "Rivastigmine", "brand": ["Exelon"] }, "class": "Acetylcholinesterase inhibitor", "mechanism": "Causes reversible inhibition of AChE", "indications": ["Mild to severe Alzheimer’s disease"], "contraindications": ["Active peptic ulcer disease", "Active GI bleeding", "Urinary or intestinal obstruction", "Hypersensitivity"], "interactions": ["No significant drug–drug interactions"], "education": ["Peripheral cholinergic effects"] },
{"id": "rn-034", "scope": ["RN"], "name": { "generic": "Memantine", "brand": ["Namenda"] }, "class": "NMDA receptor antagonist", "mechanism": "Binds to the NMDA receptor to prevent the central channel from opening, which regulates the influx of calcium and slows intracellular calcium accumulation", "indications": ["Moderate to severe dementia of the Alzheimer’s type"], "contraindications": ["Hypersensitivity"], "interactions": ["Carbonic anhydrase inhibitors", "Sodium bicarbonate", "Thiazide diuretics"], "education": ["Report severe nausea, vomiting, diarrhea, anorexia, weight loss, dehydration, or signs of GI bleeding"] },
{"id": "rn-035", "scope": ["RN"], "name": { "generic": "Benztropine mesylate", "brand": ["Cogentin"] }, "class": "Anticholinergic", "mechanism": "Exerts a direct inhibitory effect upon the parasympathetic nervous system by blocking muscarinic receptors in the striatum", "indications": ["As adjunct therapy for all forms of parkinsonism", "For control of extrapyramidal disorders (except tardive dyskinesia) caused by neuroleptic drugs"], "contraindications": ["Children ≤3 years of age", "Hypersensitivity"], "interactions": ["Antihistamines", "First-generation antipsychotics", "TCAs", "Cholinergic agonists (parasympathomimetics)"], "education": ["Report gastrointestinal complaints, fever, or heat intolerance"] },
{"id": "rn-036", "scope": ["RN"], "name": { "generic": "Trihexyphenidyl hydrochloride", "brand": ["Artane"] }, "class": "Anticholinergic", "mechanism": "Exerts a direct inhibitory effect upon the parasympathetic nervous system by blocking muscarinic receptors in the striatum", "indications": ["As adjunct therapy for all forms of parkinsonism", "For control of extrapyramidal disorders (except tardive dyskinesia) caused by neuroleptic drugs"], "contraindications": ["Children ≤3 years of age", "Hypersensitivity"], "interactions": ["Antihistamines", "First-generation antipsychotics", "TCAs", "Cholinergic agonists (parasympathomimetics)"], "education": ["Report gastrointestinal complaints, fever, or heat intolerance"] },
{"id": "rn-037", "scope": ["RN"], "name": { "generic": "Carbidopa/Levodopa", "brand": ["Sinemet"] }, "class": "Dopaminergic", "mechanism": "Taken up by dopaminergic nerve terminals in the striatum, converted into dopamine, then released to bind dopamine receptors", "indications": ["Reduces symptoms of Parkinson's Disease by increasing dopamine synthesis"], "contraindications": ["Narrow-angle glaucoma", "Hypersensitivity"], "interactions": ["Nonselective MAOIs", "Antipsychotics (first generation)", "Pyridoxine", "Antihypertensives", "Iron salts", "Dopamine receptor antagonists"], "education": ["Report involuntary movements of the face or mouth"] },
{"id":"rn-038","scope":["RN"],"name":{"generic":"Pramipexole","brand":["Mirapex"]},"class":"Dopamine agonist, nonergot derivative","mechanism":"Selectively binds to dopamine receptor subtype that activates CNS postsynaptic dopamine receptors in the striatum","indications":["Used alone in early-stage Parkinson disease","Combined with levodopa in advanced stages of Parkinson disease"],"contraindications":["None"],"interactions":["First-generation antipsychotic drugs","Dopamine antagonists","Serotonin receptor antagonists","Hormone replacement therapy","Drugs that can cause QT interval prolongation"],"education":["Assess for involuntary movements","Be aware of sudden onset of sleep while performing ADLs","Change positions slowly"] },
{"id":"rn-039","scope":["RN"],"name":{"generic":"Bromocriptine mesylate","brand":["Parlodel"]},"class":"Dopamine agonist, ergot derivative","mechanism":"Selectively binds to dopamine receptor subtype that activates CNS postsynaptic dopamine receptors in the striatum","indications":["Used alone in early-stage Parkinson disease","Combined with levodopa in advanced stages of Parkinson disease"],"contraindications":["None"],"interactions":["First-generation antipsychotic drugs","Dopamine antagonists","Serotonin receptor antagonists","Hormone replacement therapy","Drugs that can cause QT interval prolongation"],"education":["Assess for involuntary movements","Be aware of sudden onset of sleep while performing ADLs","Change positions slowly"] },
{"id":"rn-040","scope":["RN"],"name":{"generic":"Apomorphine hydrochloride","brand":["Apokyn"]},"class":"Dopamine agonist, nonergot derivative","mechanism":"Selectively binds to dopamine receptor subtype that activates CNS postsynaptic dopamine receptors in the striatum","indications":["Used alone in early-stage Parkinson disease","Combined with levodopa in advanced stages of Parkinson disease"],"contraindications":["None"],"interactions":["First-generation antipsychotic drugs","Dopamine antagonists","Serotonin receptor antagonists","Hormone replacement therapy","Drugs that can cause QT interval prolongation"],"education":["Assess for involuntary movements","Be aware of sudden onset of sleep while performing ADLs","Change positions slowly","Routine EKG monitoring for prolonged QT interval"] },
{"id":"rn-041","scope":["RN"],"name":{"generic":"Ropinirole","brand":["Requip"]},"class":"Dopamine agonist, nonergot derivative","mechanism":"Selectively binds to dopamine receptor subtype that activates CNS postsynaptic dopamine receptors in the striatum","indications":["Used alone in early-stage Parkinson disease","Combined with levodopa in advanced stages of Parkinson disease"],"contraindications":["None"],"interactions":["First-generation antipsychotic drugs","Dopamine antagonists","Serotonin receptor antagonists","Hormone replacement therapy","Drugs that can cause QT interval prolongation"],"education":["Assess for involuntary movements","Be aware of sudden onset of sleep while performing ADLs","Change positions slowly"] },
{"id":"rn-042","scope":["RN"],"name":{"generic":"Rotigotine","brand":["Neupro"]},"class":"Dopamine agonist, nonergot derivative","mechanism":"Selectively binds to dopamine receptor subtype that activates CNS postsynaptic dopamine receptors in the striatum","indications":["Used alone in early-stage Parkinson disease","Combined with levodopa in advanced stages of Parkinson disease"],"contraindications":["None"],"interactions":["First-generation antipsychotic drugs","Dopamine antagonists","Serotonin receptor antagonists","Hormone replacement therapy","Drugs that can cause QT interval prolongation"],"education":["Assess for involuntary movements","Be aware of sudden onset of sleep while performing ADLs","Change positions slowly"] },
{"id":"rn-043","scope":["RN"],"name":{"generic":"Selegiline hydrochloride","brand":["Eldepryl"]},"class":"MAO-B inhibitor","mechanism":"Selectively and irreversibly inhibits MAO-B","indications":["Adjunctive therapy of idiopathic Parkinson disease with levodopa-carbidopa when response has decreased","Helps decrease fluctuations in motor control"],"contraindications":["Hypersensitivity"],"interactions":["Morphine","Meperidine","Tramadol","SSRIs","TCAs","Sympathomimetics"],"education":["Report severe headaches","Monitor for signs and symptoms of liver damage","Risk for insomnia"] },
{"id":"rn-044","scope":["RN"],"name":{"generic":"Safinamide","brand":["Xadago"]},"class":"MAO-B inhibitor","mechanism":"Selectively and irreversibly inhibits MAO-B","indications":["Adjunctive therapy of idiopathic Parkinson disease with levodopa-carbidopa when response has decreased","Helps decrease fluctuations in motor control"],"contraindications":["Hypersensitivity"],"interactions":["Morphine","Meperidine","Tramadol","SSRIs","TCAs","Sympathomimetics"],"education":["Report severe headaches","Monitor for signs and symptoms of liver damage"] },
{"id":"rn-045","scope":["RN"],"name":{"generic":"Rasagiline","brand":["Azilect"]},"class":"MAO-B inhibitor","mechanism":"Selectively and irreversibly inhibits MAO-B","indications":["Adjunctive therapy of idiopathic Parkinson disease with levodopa-carbidopa when response has decreased","Helps decrease fluctuations in motor control"],"contraindications":["Hypersensitivity"],"interactions":["Morphine","Meperidine","Tramadol","SSRIs","TCAs","Sympathomimetics"],"education":["Report severe headaches","Monitor for signs and symptoms of liver damage"] },
{"id":"rn-046","scope":["RN"],"name":{"generic":"Entacapone","brand":["Comtan"]},"class":"COMT inhibitor","mechanism":"Prevents destruction of levodopa in the intestine and peripheral tissues and decreases production of levodopa metabolites that compete for transport across the blood–brain barrier","indications":["Adjunctive to levodopa in the treatment of Parkinson disease"],"contraindications":["Psychotic disorders with risk of symptom exacerbation"],"interactions":["Methyldopa","Dobutamine","Isoproterenol","Nonselective MAOIs"],"education":["Monitor for liver disease","Change positions slowly"] },
{"id":"rn-047","scope":["RN"],"name":{"generic":"Tolcapone","brand":["Tasmar"]},"class":"COMT inhibitor","mechanism":"Prevents destruction of levodopa in the intestine and peripheral tissues and decreases production of levodopa metabolites that compete for transport across the blood–brain barrier","indications":["Adjunctive to levodopa in the treatment of Parkinson disease"],"contraindications":["Psychotic disorders with risk of symptom exacerbation"],"interactions":["Methyldopa","Dobutamine","Isoproterenol","Nonselective MAOIs"],"education":["Monitor for liver disease","Change positions slowly"] }, 
{"id":"rn-048","scope":["RN"],"name":{"generic":"Amantadine","brand":["Gocovri"]},"class":"Dopamine antagonist","mechanism":"Increases release of dopamine from vesicles in presynaptic neurons, blocks reuptake of dopamine into presynaptic neurons, and blocks cholinergic, NMDA, and glutamate receptors","indications":["Reduction of Parkinson disease symptoms","Management of levodopa-induced dyskinesia"],"contraindications":["May exacerbate heart failure","Lowered seizure threshold","Angle-closure glaucoma"],"interactions":["CNS stimulants","Anticholinergics","Quinidine","Live vaccines"],"education":["High risk for suicide","Light sensitivity"] },
{"id":"rn-049","scope":["RN"],"name":{"generic":"Interferon beta-1a","brand":["Avonex"]},"class":"Interferons","mechanism":"Enhances suppressor T-cell activity, reduces pro-inflammatory cytokine production, down-regulates antigen presentation, and inhibits lymphocyte trafficking across the blood–brain barrier","indications":["Relapsing forms of multiple sclerosis"],"contraindications":["Hypersensitivity to interferon beta","Hypersensitivity to albumin or any drug ingredient"],"interactions":["Hypersensitivity to albumin, mannitol, or E. coli–derived products","Chemotherapeutic agents","Bone marrow suppressing drugs","Live vaccines"],"education":["Rotate injection sites","Monitor for symptoms of hypo- and hyperthyroidism","Expect flu-like symptoms on day of injection"] },
{"id":"rn-050","scope":["RN"],"name":{"generic":"Interferon beta-1b","brand":["Betaseron"]},"class":"Interferons","mechanism":"Enhances suppressor T-cell activity, reduces pro-inflammatory cytokine production, down-regulates antigen presentation, and inhibits lymphocyte trafficking across the blood–brain barrier","indications":["Relapsing forms of multiple sclerosis"],"contraindications":["Hypersensitivity to interferon beta","Hypersensitivity to albumin or any drug ingredient"],"interactions":["Hypersensitivity to albumin, mannitol, or E. coli–derived products","Chemotherapeutic agents","Bone marrow suppressing drugs","Live vaccines"],"education":["Rotate injection sites","Monitor for symptoms of hypo- and hyperthyroidism","Expect flu-like symptoms on day of injection"] },
{"id":"rn-051","scope":["RN"],"name":{"generic":"Teriflunomide","brand":["Aubagio"]},"class":"Immunomodulator","mechanism":"Inhibits dihydroorotate dehydrogenase, a mitochondrial enzyme involved in pyrimidine synthesis","indications":["Relapsing forms of multiple sclerosis"],"contraindications":["Hypersensitivity","Pregnancy or breastfeeding","Active acute or long-term infections","Severe hepatic impairment","Immunocompromised state"],"interactions":["Other immunosuppressive drugs","Other hepatotoxic drugs","Oral contraceptives","Warfarin","HMG-CoA reductase inhibitors","Live vaccines"],"education":["Use effective contraceptive barrier","Rule out latent TB before initiating therapy","Monitor for signs and symptoms of liver injury"] },
{"id":"rn-052","scope":["RN"],"name":{"generic":"Monomethyl fumarate","brand":["Bafiertam"]},"class":"Immunomodulator","mechanism":"Inhibits dihydroorotate dehydrogenase, a mitochondrial enzyme involved in pyrimidine synthesis","indications":["Relapsing forms of multiple sclerosis"],"contraindications":["Hypersensitivity","Pregnancy or breastfeeding","Active acute or long-term infections","Severe hepatic impairment","Immunocompromised state"],"interactions":["Other immunosuppressive drugs","Other hepatotoxic drugs","Oral contraceptives","Warfarin","HMG-CoA reductase inhibitors","Live vaccines"],"education":["Use effective contraceptive barrier","Rule out latent TB before initiating therapy","Monitor for signs and symptoms of liver injury"] },
{"id":"rn-053","scope":["RN"],"name":{"generic":"Glatiramer acetate","brand":["Copaxone"]},"class":"Immunomodulator","mechanism":"Inhibits dihydroorotate dehydrogenase, a mitochondrial enzyme involved in pyrimidine synthesis","indications":["Relapsing forms of multiple sclerosis"],"contraindications":["Hypersensitivity","Pregnancy or breastfeeding","Active acute or long-term infections","Severe hepatic impairment","Immunocompromised state"],"interactions":["Other immunosuppressive drugs","Other hepatotoxic drugs","Oral contraceptives","Warfarin","HMG-CoA reductase inhibitors","Live vaccines"],"education":["Use effective contraceptive barrier","Rule out latent TB before initiating therapy","Monitor for signs and symptoms of liver injury"] },
{"id":"rn-054","scope":["RN"],"name":{"generic":"Alemtuzumab","brand":["Lemtrada"]},"class":"Monoclonal antibody","mechanism":"Targets CD52 protein on lymphocytes, natural killer cells, monocytes, and macrophages, leading to antibody-dependent cellular cytolysis","indications":["Reduces frequency and severity of relapses in relapsing-remitting and secondary progressive multiple sclerosis"],"contraindications":["Hypersensitivity or anaphylaxis to alemtuzumab","HIV infection","Active infection","Pregnancy","Active hepatitis B","History of life-threatening infusion reactions"],"interactions":["Antineoplastics","Immunosuppressive or immunomodulatory drugs"],"education":["Monitor for post-infusion reactions","Increased risk of malignancies","Report signs and symptoms of hypo- or hyperthyroidism"] },
{"id":"rn-055","scope":["RN"],"name":{"generic":"Ocrelizumab","brand":["Ocrevus"]},"class":"Monoclonal antibody","mechanism":"Targets CD52 protein on lymphocytes, natural killer cells, monocytes, and macrophages, leading to antibody-dependent cellular cytolysis","indications":["Reduces frequency and severity of relapses in relapsing-remitting and secondary progressive multiple sclerosis"],"contraindications":["Hypersensitivity or anaphylaxis to monoclonal antibodies","HIV infection","Active infection","Pregnancy","Active hepatitis B","History of life-threatening infusion reactions"],"interactions":["Antineoplastics","Immunosuppressive or immunomodulatory drugs"],"education":["Monitor for post-infusion reactions","Increased risk of malignancies","Report signs and symptoms of hypo- or hyperthyroidism"] },
{"id":"rn-056","scope":["RN"],"name":{"generic":"Natalizumab","brand":["Tysabri"]},"class":"Monoclonal antibody","mechanism":"Targets CD52 protein on lymphocytes, natural killer cells, monocytes, and macrophages, leading to antibody-dependent cellular cytolysis","indications":["Reduces frequency and severity of relapses in relapsing-remitting and secondary progressive multiple sclerosis"],"contraindications":["Hypersensitivity or anaphylaxis to natalizumab","HIV infection","Active infection","Pregnancy","Active hepatitis B","History of life-threatening infusion reactions"],"interactions":["Antineoplastics","Immunosuppressive or immunomodulatory drugs"],"education":["Monitor for post-infusion reactions","Increased risk of malignancies","Report signs and symptoms of hypo- or hyperthyroidism"] },
{"id":"rn-057","scope":["RN"],"name":{"generic":"Siponimod fumaric acid","brand":["Mayzent"]},"class":"S1P receptor modulator","mechanism":"Modulates immune cell trafficking by sequestering autoreactive lymphocytes in lymphoid organs, reducing their recirculation and infiltration into the CNS","indications":["Reduces relapse in relapsing-remitting and secondary progressive multiple sclerosis","Reduces symptoms in clinically isolated syndrome"],"contraindications":["CYP2C9 genotype restrictions","In the past 6 months: unstable angina, myocardial infarction, transient ischemic attack/stroke, Class III/IV heart failure, Mobitz II or third-degree heart block"],"interactions":["Hepatotoxic drugs","Class Ia or Class III antiarrhythmic drugs","Antineoplastics","Immunosuppressive or immune-modulating therapies","Live vaccines","Drugs that slow heart rate or atrioventricular conduction"],"education":["Increased risk for malignancies","Monitor for liver injury","Monitor for neurological changes"] },
{"id":"rn-058","scope":["RN"],"name":{"generic":"Baclofen","brand":["Lioresal"]},"class":"Muscle relaxant - centrally acting","mechanism":"Inhibits GABA receptors in the spinal cord, restricts calcium influx, reduces presynaptic neurotransmitter release in excitatory spinal pathways, decreasing nerve impulse transmission to skeletal muscles and reducing spasticity","indications":["Reversible muscle spasticity associated with neuromuscular diseases such as multiple sclerosis and spinal cord injuries"],"contraindications":["May exacerbate symptoms of heart failure"],"interactions":["Agents causing CNS depression","Alcohol","Anticholinergic agents"],"education":["Monitor for CNS depression of parasympathetic reflexes"] },
{"id":"rn-059","scope":["RN"],"name":{"generic":"Dantrolene sodium","brand":["Dantrium"]},"class":"Muscle relaxant - peripherally acting","mechanism":"Inhibits release of calcium from the sarcoplasmic reticulum within skeletal muscle cells, reducing muscle contraction","indications":["Reversible muscle spasticity associated with neuromuscular diseases such as multiple sclerosis and spinal cord injuries","Treatment and prevention of malignant hyperthermia"],"contraindications":["May exacerbate symptoms of heart failure"],"interactions":["Agents causing CNS depression","Alcohol","Anticholinergic agents"],"education":["Monitor for CNS depression of parasympathetic reflexes"] },
{"id":"rn-060","scope":["RN"],"name":{"generic":"Gabapentin","brand":["Neurontin"]},"class":"Gamma-Aminobutyric Acid Structural Analog","mechanism":"Binds with calcium channels on nerve terminals, inhibiting neuronal calcium influx","indications":["Focal seizures","Neuropathic pain"],"contraindications":["Hypersensitivity"],"interactions":["CNS depressants","Alcohol","ACE inhibitors","Thiazolidinediones"],"education":["Use as adjunct to antiseizure medication","Monitor for CNS depression","Risk for dependence"] },
{"id":"rn-061","scope":["RN"],"name":{"generic":"Pregabalin","brand":["Lyrica"]},"class":"Gamma-Aminobutyric Acid Structural Analog","mechanism":"Binds with calcium channels on nerve terminals, inhibiting neuronal calcium influx","indications":["Focal seizures","Neuropathic pain"],"contraindications":["Hypersensitivity"],"interactions":["CNS depressants","Alcohol","ACE inhibitors","Thiazolidinediones"],"education":["Use as adjunct to antiseizure medication","Monitor for CNS depression","Risk for dependence"] },
{"id":"rn-062","scope":["RN"],"name":{"generic":"Phenytoin","brand":["Dilantin"]},"class":"Anticonvulsant - Hydantoin","mechanism":"Decreases abnormal electrical activity in the brain through voltage-dependent blockade of membrane sodium channels responsible for action potentials","indications":["Treatment of tonic-clonic and psychomotor seizures","Prevention and treatment of seizures during neurosurgery"],"contraindications":["Hypersensitivity","Prior history of acute hepatotoxicity","Bradycardia or heart block"],"interactions":["Azoles","Antineoplastic agents","Delavirdine","Neuromuscular blocking agents","Warfarin","Calcium channel blockers","Antilipemic agents","Antacids"],"education":["Routine laboratory testing required during titration"] },
{"id":"rn-063","scope":["RN"],"name":{"generic":"Phenobarbital","brand":["Luminal"]},"class":"Barbiturate","mechanism":"Inhibits the central nervous system by enhancing GABA activity","indications":["Seizures","Benzodiazepine withdrawal"],"contraindications":["Hypersensitivity","Hepatic failure","Respiratory disease"],"interactions":["Anticoagulants","Corticosteroids","Griseofulvin","Doxycycline","Phenytoin","Sodium valproate","Valproic acid","MAOIs","Estradiol, estrone, progesterone, and other steroidal hormones","Other CNS depressants"],"education":["Routine laboratory testing required during titration"] }, 
{"id":"rn-064","scope":["RN"],"name":{"generic":"Ethosuximide","brand":["Zarontin"]},"class":"Anticonvulsant - Succinate","mechanism":"Blocks calcium channels in the brain","indications":["Seizures"],"contraindications":["Hypersensitivity"],"interactions":["Phenytoin","Valproic acid"],"education":["Routine laboratory testing required during titration"] },
{"id":"rn-065","scope":["RN"],"name":{"generic":"Clonazepam","brand":["Klonopin"]},"class":"Benzodiazepine","mechanism":"Binds to benzodiazepine receptors on postsynaptic GABA-A ligand-gated chloride channel neurons in the CNS","indications":["Seizures","Short-term relief of severe anxiety"],"contraindications":["Hypersensitivity","Acute narrow-angle glaucoma","Respiratory insufficiency","Pregnancy/breastfeeding"],"interactions":["Opioids","Scopolamine","Probenecid"],"education":["Routine laboratory testing required during titration"] },
{"id":"rn-066","scope":["RN"],"name":{"generic":"Clorazepate","brand":["Tranxene"]},"class":"Benzodiazepine","mechanism":"Binds to benzodiazepine receptors on postsynaptic GABA-A ligand-gated chloride channel neurons in the CNS","indications":["Seizures","Short-term relief of severe anxiety"],"contraindications":["Hypersensitivity","Acute narrow-angle glaucoma","Respiratory insufficiency","Pregnancy/breastfeeding"],"interactions":["Opioids","Scopolamine","Probenecid"],"education":["Routine laboratory testing required during titration"] },
{"id":"rn-067","scope":["RN"],"name":{"generic":"Diazepam","brand":["Valium"]},"class":"Benzodiazepine","mechanism":"Binds to benzodiazepine receptors on postsynaptic GABA-A ligand-gated chloride channel neurons in the CNS","indications":["Seizures","Short-term relief of severe anxiety"],"contraindications":["Hypersensitivity","Acute narrow-angle glaucoma","Respiratory insufficiency","Pregnancy/breastfeeding"],"interactions":["Opioids","Scopolamine","Probenecid"],"education":["Routine laboratory testing required during titration"] },
{"id":"rn-068","scope":["RN"],"name":{"generic":"Lorazepam","brand":["Ativan"]},"class":"Benzodiazepine","mechanism":"Binds to benzodiazepine receptors on postsynaptic GABA-A ligand-gated chloride channel neurons in the CNS","indications":["Seizures","Short-term relief of severe anxiety"],"contraindications":["Hypersensitivity","Acute narrow-angle glaucoma","Respiratory insufficiency","Pregnancy/breastfeeding"],"interactions":["Opioids","Scopolamine","Probenecid"],"education":["Routine laboratory testing required during titration"] },
{"id":"rn-069","scope":["RN"],"name":{"generic":"Carbamazepine","brand":["Tegretol"]},"class":"Anticonvulsant - Iminostilbenes","mechanism":"Inhibits neuronal excitability by enhancing GABA activity","indications":["Seizures"],"contraindications":["Hypersensitivity","Bone marrow suppression"],"interactions":["TCAs","MAOIs","Nefazodone","Delavirdine"],"education":["Routine laboratory testing required during titration","Monitor for risk of toxic epidermal necrolysis and Stevens-Johnson syndrome"] },
{"id":"rn-070","scope":["RN"],"name":{"generic":"Valproic acid","brand":["Depakote"]},"class":"Anticonvulsant - Valproates","mechanism":"Acts on GABA levels in the CNS by blocking voltage-gated sodium, potassium, and calcium channels, decreasing neuronal excitability","indications":["Seizures","Bipolar disorder"],"contraindications":["Hypersensitivity","Hepatic insufficiency","Bone marrow depression","Pregnancy"],"interactions":["Amitriptyline/nortriptyline","Carbamazepine","Clonazepam","Diazepam","Ethosuximide","Lamotrigine","Phenobarbital","Phenytoin","Propofol","Rufinamide","Tolbutamide","Warfarin","Zidovudine"],"education":["Routine laboratory testing required during titration","Monitor for pancreatitis","Monitor for abnormal bleeding and clotting times"] }, 
{"id":"rn-071","scope":["RN"],"name":{"generic":"Levetiracetam","brand":["Keppra"]},"class":"Anticonvulsant - Pyrrolidine","mechanism":"Binds to synaptic vesicle protein 2A (SV2A), decreasing the rate of vesicle neurotransmitter release in a calcium-dependent manner","indications":["Seizures"],"contraindications":["Hypersensitivity","Renal impairment"],"interactions":["Baclofen","Melatonin","Opioids","Trazodone"],"education":["Routine laboratory testing required during titration","Monitor for life-threatening behavioral manifestations and psychotic symptoms"] },
{"id":"rn-072","scope":["RN"],"name":{"generic":"Lamotrigine","brand":["Lamictal"]},"class":"Anticonvulsant - phenyltriazine","mechanism":"Blocks voltage-gated sodium ion channels and inhibits presynaptic glutamate and aspartate release","indications":["Seizures","Bipolar disorder"],"contraindications":["Hypersensitivity"],"interactions":["Valproate","Oral contraceptives","Sodium channel blockers"],"education":["Routine laboratory testing required during titration"] },
{"id":"rn-073","scope":["RN"],"name":{"generic":"Topiramate","brand":["Topamax"]},"class":"Anticonvulsant","mechanism":"Stimulates GABA-A receptor activity at non-benzodiazepine receptor sites and reduces glutamate activity","indications":["Partial or generalized seizures"],"contraindications":["Hypersensitivity"],"interactions":["Carbonic anhydrase inhibitors","CNS depressants","Digoxin"],"education":["Routine laboratory testing required during titration"] },
{"id":"rn-074","scope":["RN"],"name":{"generic":"Lacosamide","brand":["Vimpat"]},"class":"Anticonvulsant","mechanism":"Blocks voltage-gated sodium ion channels and decreases brain activity","indications":["Partial seizures"],"contraindications":["Hypersensitivity","Second- and third-degree atrioventricular (AV) block"],"interactions":["None"],"education":["Routine laboratory testing required during titration"] },
{"id":"rn-075","scope":["RN"],"name":{"generic":"Zonisamide","brand":["Zonegran"]},"class":"Anticonvulsant - Sulfonamide","mechanism":"Blocks voltage-gated sodium ion channels and inhibits presynaptic glutamate and aspartate release","indications":["Adjunctive therapy for partial seizures"],"contraindications":["Hypersensitivity"],"interactions":["CNS depressants"],"education":["Routine laboratory testing required during titration"] },
{"id":"rn-076","scope":["RN"],"name":{"generic":"Eletriptan","brand":["Relpax"]},"class":"Serotonin agonist","mechanism":"Selectively binds to serotonin receptors 5-HT1B and 5-HT1D, inducing vasoconstriction of cranial arteries","indications":["To treat migraine headaches","To treat cluster headaches"],"contraindications":["Hypersensitivity","Ischemic coronary disease","Stroke","Peripheral vascular disease","Uncontrolled hypertension","Pregnancy"],"interactions":["Ergot-containing drugs","MAOIs","SSRIs","TCAs","Serotonin and norepinephrine reuptake inhibitors","Tricyclic antidepressants"],"education":["Monitor response to medication","Identify triggers"] },
{"id":"rn-077","scope":["RN"],"name":{"generic":"Rizatriptan","brand":["Maxalt"]},"class":"Serotonin agonist","mechanism":"Selectively binds to serotonin receptors 5-HT1B and 5-HT1D, inducing vasoconstriction of cranial arteries","indications":["To treat migraine headaches","To treat cluster headaches"],"contraindications":["Hypersensitivity","Ischemic coronary disease","Stroke","Peripheral vascular disease","Uncontrolled hypertension","Pregnancy"],"interactions":["Ergot-containing drugs","MAOIs","SSRIs","TCAs","Serotonin and norepinephrine reuptake inhibitors","Tricyclic antidepressants"],"education":["Monitor response to medication","Identify triggers"] },
{"id":"rn-078","scope":["RN"],"name":{"generic":"Sumatriptan","brand":["Imitrex"]},"class":"Serotonin agonist","mechanism":"Selectively binds to serotonin receptors 5-HT1B and 5-HT1D, inducing vasoconstriction of cranial arteries","indications":["To treat migraine headaches","To treat cluster headaches"],"contraindications":["Hypersensitivity","Ischemic coronary disease","Stroke","Peripheral vascular disease","Uncontrolled hypertension","Pregnancy"],"interactions":["Ergot-containing drugs","MAOIs","SSRIs","TCAs","Serotonin and norepinephrine reuptake inhibitors","Tricyclic antidepressants"],"education":["Monitor response to medication","Identify triggers","Risk of adverse thrombotic events"] },
{"id":"rn-079","scope":["RN"],"name":{"generic":"Zolmitriptan","brand":["Zomig"]},"class":"Serotonin agonist","mechanism":"Selectively binds to serotonin receptors 5-HT1B and 5-HT1D, inducing vasoconstriction of cranial arteries","indications":["To treat migraine headaches","To treat cluster headaches"],"contraindications":["Hypersensitivity","Ischemic coronary disease","Stroke","Peripheral vascular disease","Uncontrolled hypertension","Pregnancy"],"interactions":["Ergot-containing drugs","MAOIs","SSRIs","TCAs","Serotonin and norepinephrine reuptake inhibitors","Tricyclic antidepressants"],"education":["Monitor response to medication","Identify triggers"] },
{"id":"rn-080","scope":["RN"],"name":{"generic":"Ergotamine tartrate","brand":["Cafergot"]},"class":"Alpha-adrenergic blocker - Ergot alkaloid","mechanism":"Inhibits norepinephrine and directly stimulates vascular smooth muscle, causing vasoconstriction","indications":["Migraine and vascular headaches"],"contraindications":["Hypersensitivity","Vasoconstrictive conditions","Renal insufficiency","Hepatic insufficiency","Myocardial ischemia or infarction"],"interactions":["Ritonavir","Indinavir","Erythromycin","Clarithromycin","Troleandomycin"],"education":["Monitor response to medication","Identify triggers"] },
{"id":"rn-081","scope":["RN"],"name":{"generic":"Lasmiditan","brand":["Reyvow"]},"class":"Selective serotonin receptor agonist","mechanism":"Decreases the release of neuropeptides and glutamate, inhibiting neuronal firing","indications":["To treat migraine and cluster headaches"],"contraindications":["Hypersensitivity"],"interactions":["SSRIs","Serotonin and norepinephrine reuptake inhibitors","TCAs"],"education":["Monitor response to medication","Identify triggers"] },
{"id":"rn-082","scope":["RN"],"name":{"generic":"Rimegepant","brand":["Nurtec"]},"class":"CGRP receptor antagonist","mechanism":"Binds to CGRP receptors, decreasing inflammation in the meninges of the brain","indications":["To treat migraine headaches"],"contraindications":["Hypersensitivity"],"interactions":["Ritonavir","Indinavir","Amiodarone","Cyclosporine","Quinidine"],"education":["Monitor response to medication","Identify triggers"] },
{"id":"rn-083","scope":["RN"],"name":{"generic":"Acetazolamide","brand":["Diamox"]},"class":"Carbonic Anhydrase Inhibitor (CAI)","mechanism":"Blocks carbonic anhydrase in the renal tubule, decreasing bicarbonate secretion and reducing cerebrospinal fluid and intracranial pressure","indications":["Idiopathic intracranial hypertension","Glaucoma","Heart failure","Altitude sickness","Epilepsy"],"contraindications":["Hypersensitivity","Hyponatremia","Hypokalemia","Hepatic disease"],"interactions":["Ritonavir","Indinavir","Amiodarone","Cyclosporine","Quinidine"],"education":["Monitor for symptoms of cerebral edema and intracranial hypertension","Monitor for metabolic acidosis and electrolyte imbalances"] },
{"id":"rn-084","scope":["RN"],"name":{"generic":"Mannitol","brand":["Osmitrol"]},"class":"Osmotic diuretic","mechanism":"Causes osmosis from intracellular to extracellular fluid, drawing water out of the brain parenchyma into the intravascular space","indications":["Increased intracranial pressure and cerebral edema","Increased intraocular pressure"],"contraindications":["Hypersensitivity","Anuria","Severe hypovolemia","Preexisting pulmonary edema","Active intracranial bleeding except during craniotomy"],"interactions":["Aminoglycosides","Cyclosporine","Digoxin","Other diuretics"],"education":["Monitor for symptoms of cerebral edema and intracranial hypertension","Monitor for metabolic acidosis and electrolyte imbalances"] },
{"id":"rn-085","scope":["RN"],"name":{"generic":"Amitriptyline","brand":["Elavil"]},"class":"Tricyclic antidepressant (TCA)","mechanism":"Blocks the reuptake of norepinephrine and serotonin at the presynaptic nerve endings","indications":["Major depressive disorder","Primary insomnia","Anxiety","Chronic pain syndromes"],"contraindications":["Children <12 years","Recent myocardial infarction","Uncompensated heart failure","Cardiac dysrhythmia"],"interactions":["Tramadol","Anticholinergic agents","Fluvoxamine","Phenothiazines","Haloperidol","MAOIs","Calcium channel blockers","Beta blockers","Digoxin","CNS depressants"],"education":["Anticholinergic effects: blurred vision, dry mouth, constipation, urinary retention","Decreases seizure threshold","can take 2 weeks to see effects and 4-6 weeks for full therapeutic effects"]},
{"id":"rn-086","scope":["RN"],"name":{"generic":"Citalopram","brand":["Celexa"]},"class":"Selective serotonin reuptake inhibitor (SSRI)","mechanism":"Selectively blocks neuronal reuptake of serotonin; adaptive cellular changes occur with prolonged blockade","indications":["Major depressive disorder"],"contraindications":["Increased risk for bleeding"],"interactions":["Tramadol","MAOIs","Warfarin","Aspirin","NSAIDs"],"education":["Separate MAOIs and SSRIs by at least 5 weeks to prevent serotonin syndrome","can take 2 weeks to see effects and 4-6 weeks for full therapeutic effects"]},
{"id":"rn-087","scope":["RN"],"name":{"generic":"Escitalopram","brand":["Lexapro"]},"class":"Selective serotonin reuptake inhibitor (SSRI)","mechanism":"Selectively blocks neuronal reuptake of serotonin; adaptive cellular changes occur with prolonged blockade","indications":["Major depression (≥8 years)","OCD (≥7 years)","GAD","Panic disorder","PMDD","Bulimia nervosa","Bipolar depression (with olanzapine)","Treatment-resistant depression (with olanzapine)"],"contraindications":["Increased risk for bleeding"],"interactions":["Tramadol","MAOIs","Warfarin","Aspirin","NSAIDs"],"education":["Separate MAOIs and SSRIs by at least 5 weeks to prevent serotonin syndrome","can take 2 weeks to see effects and 4-6 weeks for full therapeutic effects"]},
{"id":"rn-088","scope":["RN"],"name":{"generic":"Fluoxetine","brand":["Prozac"]},"class":"Selective serotonin reuptake inhibitor (SSRI)","mechanism":"Selectively blocks neuronal reuptake of serotonin; adaptive cellular changes occur with prolonged blockade","indications":["Major depression (≥8 years)","OCD (≥7 years)","Panic disorder","PMDD","Bulimia nervosa","Bipolar depression (with olanzapine)","Treatment-resistant depression (with olanzapine)"],"contraindications":["Increased risk for bleeding"],"interactions":["Tramadol","MAOIs","Warfarin","Aspirin","NSAIDs"],"education":["Separate MAOIs and SSRIs by at least 5 weeks to prevent serotonin syndrome","can take 2 weeks to see effects and 4-6 weeks for full therapeutic effects"]},
{"id":"rn-089","scope":["RN"],"name":{"generic":"Paroxetine","brand":["Paxil"]},"class":"Selective serotonin reuptake inhibitor (SSRI)","mechanism":"Selectively blocks neuronal reuptake of serotonin; adaptive cellular changes occur with prolonged blockade","indications":["Major depressive disorder","OCD","Panic disorder","Social phobia","GAD","PTSD","PMDD"],"contraindications":["Increased risk for bleeding"],"interactions":["Tramadol","MAOIs","Warfarin","Aspirin","NSAIDs"],"education":["Separate MAOIs and SSRIs by at least 5 weeks to prevent serotonin syndrome","can take 2 weeks to see effects and 4-6 weeks for full therapeutic effects"]},
{"id":"rn-090","scope":["RN"],"name":{"generic":"Sertraline","brand":["Zoloft"]},"class":"Selective serotonin reuptake inhibitor (SSRI)","mechanism":"Selectively blocks neuronal reuptake of serotonin; adaptive cellular changes occur with prolonged blockade","indications":["Major depression","PMDD","OCD","PTSD","Social anxiety disorder","Panic disorder"],"contraindications":["Increased risk for bleeding"],"interactions":["Tramadol","MAOIs","Warfarin","Aspirin","NSAIDs"],"education":["Separate MAOIs and SSRIs by at least 5 weeks to prevent serotonin syndrome","can take 2 weeks to see effects and 4-6 weeks for full therapeutic effects"]},
{"id":"rn-091","scope":["RN"],"name":{"generic":"Venlafaxine","brand":["Effexor"]},"class":"Serotonin-norepinephrine reuptake inhibitor (SNRI)","mechanism":"Powerful blockade of norepinephrine and serotonin reuptake with weak dopamine reuptake blockade","indications":["Major depressive disorder","Panic disorder","Social phobia","Generalized anxiety disorder"],"contraindications":["Hypertension"],"interactions":["MAOIs","Antiplatelet agents","Anticoagulants"],"education":["Separate MAOIs and SNRIs by at least 14 days to prevent serotonin syndrome","can take 2 weeks to see effects and 4-6 weeks for full therapeutic effects"]},
{"id":"rn-092","scope":["RN"],"name":{"generic":"Duloxetine","brand":["Cymbalta"]},"class":"Serotonin-norepinephrine reuptake inhibitor (SNRI)","mechanism":"Powerful blockade of norepinephrine and serotonin reuptake with weak dopamine reuptake blockade","indications":["Major depressive disorder","Diabetic peripheral neuropathic pain","Fibromyalgia","Generalized anxiety disorder","Social anxiety","Panic disorder","Chronic musculoskeletal pain","Pediatric depression","Pediatric GAD","Pediatric fibromyalgia"],"contraindications":["Hypertension"],"interactions":["MAOIs","Antiplatelet agents","Anticoagulants"],"education":["Separate MAOIs and SNRIs by at least 14 days to prevent serotonin syndrome","can take 2 weeks to see effects and 4-6 weeks for full therapeutic effects"]}, 
{"id":"rn-093","scope":["RN"],"name":{"generic":"Levomilnacipran","brand":["Fetzima"]},"class":"Serotonin-norepinephrine reuptake inhibitor (SNRI)","mechanism":"Powerful blockade of norepinephrine and serotonin reuptake with weak dopamine reuptake blockade","indications":["Major depressive disorder"],"contraindications":["Hypertension"],"interactions":["MAOIs","Antiplatelet agents","Anticoagulants"],"education":["Separate MAOIs and SNRIs by at least 14 days to prevent serotonin syndrome","can take 2 weeks to see effects and 4-6 weeks for full therapeutic effects"]},
{"id":"rn-094","scope":["RN"],"name":{"generic":"Bupropion hydrochloride","brand":["Wellbutrin"]},"class":"Norepinephrine-dopamine reuptake inhibitor (NDRI)","mechanism":"Inhibits the reuptake of dopamine, norepinephrine, and serotonin","indications":["Depression","Seasonal affective disorder","Smoking cessation"],"contraindications":["Hypersensitivity","Seizure disorders","Conditions that lower seizure threshold (anorexia nervosa, bulimia nervosa, alcohol or substance withdrawal)"],"interactions":["Sertraline","Fluoxetine","Paroxetine","MAOIs within 14 days"],"education":["Separate MAOIs and NDRIs by at least 14 days to prevent serotonin syndrome","can take 2 weeks to see effects and 4-6 weeks for full therapeutic effects"]}, 
{"id":"rn-095","scope":["RN"],"name":{"generic":"Phenelzine sulfate","brand":["Nardil"]},"class":"Monoamine oxidase inhibitor (MAOI)","mechanism":"Irreversibly binds to the MAO-A enzyme","indications":["Major depressive disorder"],"contraindications":["Severe hepatic disease","Pheochromocytoma","Congestive heart failure","Hypersensitivity"],"interactions":["Other antidepressants","Vasoconstrictors","Sympathomimetics (amphetamines, dextromethorphan, diet pills)","Opioids","Insulin"],"education":["NDRI, SNRI, and SSRI must be stopped prior to starting MAOI","Therapeutic effects may take 2 weeks; full effect 4–6 weeks"]},
{"id":"rn-096","scope":["RN"],"name":{"generic":"Selegiline hydrochloride","brand":["Emsam"]},"class":"Monoamine oxidase inhibitor (MAOI)","mechanism":"Irreversibly binds to the MAO-A enzyme","indications":["Major depressive disorder"],"contraindications":["Severe hepatic disease","Pheochromocytoma","Congestive heart failure","Hypersensitivity"],"interactions":["Other antidepressants","Vasoconstrictors","Sympathomimetics (amphetamines, dextromethorphan, diet pills)","Opioids","Insulin"],"education":["NDRI, SNRI, and SSRI must be stopped prior to starting MAOI","Rotate transdermal patch site","Therapeutic effects may take 2 weeks; full effect 4–6 weeks"]},
{"id":"rn-097","scope":["RN"],"name":{"generic":"Mirtazapine","brand":["Remeron"]},"class":"Tetracyclic antidepressant","mechanism":"Blocks presynaptic alpha-2 adrenergic receptors increasing norepinephrine and serotonin release and blocks histamine-1 receptors","indications":["Major depressive disorder"],"contraindications":["Hypersensitivity"],"interactions":["MAOIs","Benzodiazepines","Opioids","Antihistamines"],"education":["Stop MAOI prior to initiation","Therapeutic effects may begin in 2 weeks; full effect in 4–6 weeks"]},
{"id":"rn-098","scope":["RN"],"name":{"generic":"Trazodone hydrochloride","brand":["Desyrel"]},"class":"Serotonin antagonist and reuptake inhibitor (SARI)","mechanism":"Blocks the reuptake of serotonin at the presynaptic nerve membrane","indications":["Sedation","Sleep disorders","Depression"],"contraindications":["Hypersensitivity"],"interactions":["MAOIs","Benzodiazepines","Opioids","Antihistamines"],"education":["Stop MAOI prior to initiation","Therapeutic effects may begin in 2 weeks; full effect in 4–6 weeks"]},
{"id":"rn-099","scope":["RN"],"name":{"generic":"Vortioxetine","brand":["Trintellix"]},"class":"Serotonin modulator and stimulator (SMS)","mechanism":"Inhibits the serotonin transporter increasing serotonin concentration in the synaptic cleft","indications":["Major depressive disorder"],"contraindications":["Hypersensitivity"],"interactions":["MAOIs","Benzodiazepines","Opioids","Antihistamines"],"education":["Stop MAOI prior to initiation","Therapeutic effects may begin in 2 weeks; full effect in 4–6 weeks"]},
{"id":"rn-100","scope":["RN"],"name":{"generic":"Chlorpromazine","brand":["Thorazine"]},"class":"First-generation antipsychotic (typical)","mechanism":"Blocks dopamine-2 receptors preventing postsynaptic dopamine stimulation; exact mechanism in schizophrenia unclear","indications":["Schizophrenia","Psychotic symptoms associated with brain impairment (head trauma, tumor, stroke, alcohol withdrawal, CNS stimulant overdose)"],"contraindications":["Parkinson’s disease","Older adults with dementia","Cardiac arrhythmias or prolonged QTc","Liver damage","Coronary artery disease","Cerebrovascular disease"],"interactions":["CNS depressants","QTc-prolonging antiarrhythmics"],"education":["Risk for extrapyramidal symptoms"]},
{"id":"rn-101","scope":["RN"],"name":{"generic":"Fluphenazine","brand":["Prolixin"]},"class":"First-generation antipsychotic (typical)","mechanism":"Blocks dopamine-2 receptors preventing postsynaptic dopamine stimulation; exact mechanism in schizophrenia unclear","indications":["Schizophrenia","Psychotic symptoms associated with brain impairment (head trauma, tumor, stroke, alcohol withdrawal, CNS stimulant overdose)"],"contraindications":["Parkinson’s disease","Older adults with dementia","Cardiac arrhythmias or prolonged QTc","Liver damage","Coronary artery disease","Cerebrovascular disease"],"interactions":["CNS depressants","QTc-prolonging antiarrhythmics"],"education":["Risk for extrapyramidal symptoms"]},
{"id":"rn-102","scope":["RN"],"name":{"generic":"Haloperidol","brand":["Haldol"]},"class":"First-generation antipsychotic (typical)","mechanism":"Blocks dopamine-2 receptors preventing postsynaptic dopamine stimulation; exact mechanism in schizophrenia unclear","indications":["Schizophrenia","Psychotic symptoms associated with brain impairment (head trauma, tumor, stroke, alcohol withdrawal, CNS stimulant overdose)"],"contraindications":["Parkinson’s disease","Older adults with dementia","Cardiac arrhythmias or prolonged QTc","Liver damage","Coronary artery disease","Cerebrovascular disease"],"interactions":["CNS depressants","QTc-prolonging antiarrhythmics"],"education":["Risk for extrapyramidal symptoms"]},
{"id":"rn-103","scope":["RN"],"name":{"generic":"Aripiprazole","brand":["Abilify"]},"class":"Second-generation antipsychotic (atypical antipsychotic)","mechanism":"Blocks dopamine and serotonin receptors in the brain","indications":["Schizophrenia","Major depressive disorder","Bipolar disorder","Irritability related to autism spectrum disorder","Tourette syndrome"],"contraindications":["Dementia-related psychosis","Hypersensitivity"],"interactions":["Carbamazepine","Cimetidine","Ranitidine","Fluoxetine","Paroxetine","Erythromycin","Amitriptyline"],"education":["Risk for compulsive and uncontrollable urges","Risk for hyperprolactinemia","Risk for anticholinergic effects","Full therapeutic effects will not occur immediately"]}, 
{"id":"rn-104","scope":["RN"],"name":{"generic":"Cariprazine","brand":["Vraylar"]},"class":"Second-generation antipsychotic (atypical antipsychotic)","mechanism":"Blocks dopamine and serotonin receptors in the brain","indications":["Schizophrenia","Mania and depression related to bipolar disorder","Major depressive disorder"],"contraindications":["Dementia-related psychosis","Hypersensitivity"],"interactions":["Carbamazepine","Cimetidine","Ranitidine","Fluoxetine","Paroxetine","Erythromycin","Amitriptyline"],"education":["Risk for hyperprolactinemia","Risk for anticholinergic effects","Full therapeutic effects will not occur immediately"]},
{"id":"rn-105","scope":["RN"],"name":{"generic":"Clozapine","brand":["Clozaril"]},"class":"Second-generation antipsychotic (atypical antipsychotic)","mechanism":"Blocks dopamine and serotonin receptors in the brain","indications":["Schizophrenia"],"contraindications":["Dementia-related psychosis","Hypersensitivity"],"interactions":["Carbamazepine","Cimetidine","Ranitidine","Fluoxetine","Paroxetine","Erythromycin","Amitriptyline"],"education":["Risk for hyperprolactinemia","Risk for anticholinergic effects","Full therapeutic effects will not occur immediately"]},
{"id":"rn-106","scope":["RN"],"name":{"generic":"Lurasidone","brand":["Latuda"]},"class":"Second-generation antipsychotic (atypical antipsychotic)","mechanism":"Blocks dopamine and serotonin receptors in the brain","indications":["Schizophrenia","Bipolar depression in clients age 13 and older"],"contraindications":["Dementia-related psychosis","Hypersensitivity"],"interactions":["Carbamazepine","Cimetidine","Ranitidine","Fluoxetine","Paroxetine","Erythromycin","Amitriptyline"],"education":["Risk for hyperprolactinemia","Risk for anticholinergic effects","Full therapeutic effects will not occur immediately"]},
{"id":"rn-107","scope":["RN"],"name":{"generic":"Olanzapine","brand":["Zyprexa"]},"class":"Second-generation antipsychotic (atypical antipsychotic)","mechanism":"Blocks dopamine and serotonin receptors in the brain","indications":["Schizophrenia","Manic or mixed episodes of bipolar disorder","Agitation"],"contraindications":["Dementia-related psychosis","Hypersensitivity"],"interactions":["Carbamazepine","Cimetidine","Ranitidine","Fluoxetine","Paroxetine","Erythromycin","Amitriptyline"],"education":["Risk for hyperprolactinemia","Risk for anticholinergic effects","Full therapeutic effects will not occur immediately"]},
{"id":"rn-108","scope":["RN"],"name":{"generic":"Paliperidone","brand":["Invega"]},"class":"Second-generation antipsychotic (atypical antipsychotic)","mechanism":"Blocks dopamine and serotonin receptors in the brain","indications":["Schizoaffective disorders"],"contraindications":["Dementia-related psychosis","Hypersensitivity"],"interactions":["Carbamazepine","Cimetidine","Ranitidine","Fluoxetine","Paroxetine","Erythromycin","Amitriptyline"],"education":["Risk for hyperprolactinemia","Risk for anticholinergic effects","Full therapeutic effects will not occur immediately"]},
{"id":"rn-109","scope":["RN"],"name":{"generic":"Quetiapine","brand":["Seroquel"]},"class":"Second-generation antipsychotic (atypical antipsychotic)","mechanism":"Blocks dopamine and serotonin receptors in the brain","indications":["Schizophrenia","Depressive disorder","Acute manic episodes with bipolar disorder"],"contraindications":["Dementia-related psychosis","Hypersensitivity"],"interactions":["Carbamazepine","Cimetidine","Ranitidine","Fluoxetine","Paroxetine","Erythromycin","Amitriptyline"],"education":["Risk for hyperprolactinemia","Risk for anticholinergic effects","Full therapeutic effects will not occur immediately"]},
{"id":"rn-110","scope":["RN"],"name":{"generic":"Risperidone","brand":["Risperdal"]},"class":"Second-generation antipsychotic (atypical antipsychotic)","mechanism":"Blocks dopamine and serotonin receptors in the brain","indications":["Schizophrenia","Acute bipolar mania","Irritability and aggression associated with autism spectrum disorder"],"contraindications":["Dementia-related psychosis","Hypersensitivity"],"interactions":["Carbamazepine","Cimetidine","Ranitidine","Fluoxetine","Paroxetine","Erythromycin","Amitriptyline"],"education":["Risk for hyperprolactinemia","Risk for anticholinergic effects","Full therapeutic effects will not occur immediately"]},
{"id":"rn-111","scope":["RN"],"name":{"generic":"Ziprasidone","brand":["Geodon"]},"class":"Second-generation antipsychotic (atypical antipsychotic)","mechanism":"Blocks dopamine and serotonin receptors in the brain","indications":["Schizophrenia","Bipolar disorder"],"contraindications":["Dementia-related psychosis","Hypersensitivity"],"interactions":["Carbamazepine","Cimetidine","Ranitidine","Fluoxetine","Paroxetine","Erythromycin","Amitriptyline"],"education":["Risk for hyperprolactinemia","Risk for anticholinergic effects","Full therapeutic effects will not occur immediately"]},
{"id":"rn-112","scope":["RN"],"name":{"generic":"Lithium","brand":["Eskalith"]},"class":"Mood stabilizer","mechanism":"Affects the synthesis, release, and reuptake of acetylcholine, dopamine, GABA, and norepinephrine; stabilizes postsynaptic receptor sensitivity to neurotransmitters; has neuroprotective effects by stimulating neuronal growth","indications":["Treatment of active manic episodes","Maintenance therapy to prevent or diminish future manic episodes"],"contraindications":["Renal failure","Cardiovascular insufficiency","Addison’s disease","Untreated hypothyroidism","Children under 12 years of age","Pregnancy and breastfeeding"],"interactions":["Diuretics","Serotonergic agents","Neuromuscular blocking agents","Carbamazepine","Lithium-iodide salt combination","Theophylline"],"education":["Drink plenty of water to prevent dehydration and lithium toxicity"]},
{"id":"rn-113","scope":["RN"],"name":{"generic":"Alprazolam","brand":["Xanax"]},"class":"Benzodiazepine","mechanism":"Enhances the inhibitory effect of GABA","indications":["Anxiety","Tension and nervousness","Insomnia","Muscle relaxation","Sleepwalking or night terrors in children"],"contraindications":["Hypersensitivity","Clients under 6 months of age","Myasthenia gravis","Severe respiratory insufficiency","Severe hepatic insufficiency","Sleep apnea","Acute narrow-angle glaucoma"],"interactions":["CNS depressants","Opioids","Calcium channel blockers","Cimetidine","Disulfiram"],"education":["Risk for dependence","Notify provider if experiencing hallucinations or thoughts of suicide"]},
{"id":"rn-114","scope":["RN"],"name":{"generic":"Temazepam","brand":["Restoril"]},"class":"Benzodiazepine","mechanism":"Enhances the inhibitory effect of GABA","indications":["Anxiety","Tension and nervousness","Insomnia","Muscle relaxation","Sleepwalking or night terrors in children"],"contraindications":["Hypersensitivity","Clients under 6 months of age","Myasthenia gravis","Severe respiratory insufficiency","Severe hepatic insufficiency","Sleep apnea","Acute narrow-angle glaucoma"],"interactions":["CNS depressants","Opioids","Calcium channel blockers","Cimetidine","Disulfiram"],"education":["Notify provider if experiencing hallucinations or thoughts of suicide"]},
{"id":"rn-115","scope":["RN"],"name":{"generic":"Eszopiclone","brand":["Lunesta"]},"class":"Nonbenzodiazepine sedative-hypnotic","mechanism":"Selectively binds to specific GABA receptors","indications":["Insomnia"],"contraindications":["Hypersensitivity","Severe hepatic impairment"],"interactions":["CNS depressants","Opioids"],"education":["Establish a bedtime routine","Identify nondrug measures to manage stress and promote sleep"]},
{"id":"rn-116","scope":["RN"],"name":{"generic":"Zaleplon","brand":["Sonata"]},"class":"Nonbenzodiazepine sedative-hypnotic","mechanism":"Selectively binds to specific GABA receptors","indications":["Insomnia"],"contraindications":["Hypersensitivity","Severe hepatic impairment"],"interactions":["CNS depressants","Opioids"],"education":["Establish a bedtime routine","Identify nondrug measures to manage stress and promote sleep"]},
{"id":"rn-117","scope":["RN"],"name":{"generic":"Zolpidem","brand":["Ambien"]},"class":"Nonbenzodiazepine sedative-hypnotic","mechanism":"Selectively binds to specific GABA receptors","indications":["Short-term treatment of insomnia (immediate-release)","Decreases sleep latency and increases total sleep time (extended-release)"],"contraindications":["Hypersensitivity","Severe hepatic impairment"],"interactions":["CNS depressants","Opioids"],"education":["Establish a bedtime routine","Identify nondrug measures to manage stress and promote sleep"]},
{"id":"rn-118","scope":["RN"],"name":{"generic":"Ramelteon","brand":["Rozerem"]},"class":"Nonbenzodiazepine sedative-hypnotic","mechanism":"Selectively binds to specific GABA receptors","indications":["Insomnia"],"contraindications":["Hypersensitivity","Severe hepatic impairment"],"interactions":["CNS depressants","Opioids"],"education":["Establish a bedtime routine","Identify nondrug measures to manage stress and promote sleep"]},
{"id":"rn-119","scope":["RN"],"name":{"generic":"Suvorexant","brand":["Belsomra"]},"class":"Nonbenzodiazepine sedative-hypnotic","mechanism":"Selectively binds to specific GABA receptors","indications":["Insomnia"],"contraindications":["Hypersensitivity","Severe hepatic impairment"],"interactions":["CNS depressants","Opioids"],"education":["Establish a bedtime routine","Identify nondrug measures to manage stress and promote sleep"]},
{"id":"rn-120","scope":["RN"],"name":{"generic":"Lemborexant","brand":["Dayvigo"]},"class":"Nonbenzodiazepine sedative-hypnotic","mechanism":"Selectively binds to specific GABA receptors","indications":["Insomnia"],"contraindications":["Hypersensitivity","Severe hepatic impairment"],"interactions":["CNS depressants","Opioids"],"education":["Establish a bedtime routine","Identify nondrug measures to manage stress and promote sleep"]},
{"id":"rn-121","scope":["RN"],"name":{"generic":"Daridorexant","brand":["Quviviq"]},"class":"Nonbenzodiazepine sedative-hypnotic","mechanism":"Selectively binds to specific GABA receptors","indications":["Insomnia"],"contraindications":["Hypersensitivity","Severe hepatic impairment"],"interactions":["CNS depressants","Opioids"],"education":["Establish a bedtime routine","Identify nondrug measures to manage stress and promote sleep"]},
{"id":"rn-122","scope":["RN"],"name":{"generic":"Methylphenidate","brand":["Ritalin"]},"class":"CNS stimulant","mechanism":"Blocks the reuptake of norepinephrine and dopamine in specific areas of the brain","indications":["ADHD","Narcolepsy","Traumatic brain injury"],"contraindications":["Advanced arteriosclerosis","Symptomatic cardiovascular disease","Congenital cardiac structural abnormalities","Recent MI or angina","Severe hypertension","Heart failure","Arrhythmias","Hyperthyroidism","Glaucoma","History of substance use","History of psychiatric disorders","Tourette syndrome"],"interactions":["MAOIs or within 14 days","Alpha-1 adrenergic blockers","Phenytoin","Tricyclic antidepressants","Meperidine"],"education":["Report chest pain","Difficulty breathing","Fainting","Abnormal thinking or behavior","Increased aggression","Hallucinations","Unintended weight loss"]},
{"id":"rn-123","scope":["RN"],"name":{"generic":"Amphetamine and dextroamphetamine","brand":["Adderall"]},"class":"CNS stimulant","mechanism":"Blocks the reuptake of norepinephrine and dopamine in specific areas of the brain","indications":["ADHD","Narcolepsy","Traumatic brain injury"],"contraindications":["Advanced arteriosclerosis","Symptomatic cardiovascular disease","Congenital cardiac structural abnormalities","Recent MI or angina","Severe hypertension","Heart failure","Arrhythmias","Hyperthyroidism","Glaucoma","History of substance use","History of psychiatric disorders","Tourette syndrome"],"interactions":["MAOIs or within 14 days","Alpha-1 adrenergic blockers","Phenytoin","Tricyclic antidepressants","Meperidine"],"education":["Report chest pain","Difficulty breathing","Fainting","Abnormal thinking or behavior","Increased aggression","Hallucinations","Unintended weight loss"]},
{"id":"rn-124","scope":["RN"],"name":{"generic":"Dextroamphetamine","brand":["Xelstrym"]},"class":"CNS stimulant","mechanism":"Blocks the reuptake of norepinephrine and dopamine in specific areas of the brain","indications":["ADHD","Narcolepsy","Traumatic brain injury"],"contraindications":["Advanced arteriosclerosis","Symptomatic cardiovascular disease","Congenital cardiac structural abnormalities","Recent MI or angina","Severe hypertension","Heart failure","Arrhythmias","Hyperthyroidism","Glaucoma","History of substance use","History of psychiatric disorders","Tourette syndrome"],"interactions":["MAOIs or within 14 days","Alpha-1 adrenergic blockers","Phenytoin","Tricyclic antidepressants","Meperidine"],"education":["Report chest pain","Difficulty breathing","Fainting","Abnormal thinking or behavior","Increased aggression","Hallucinations","Unintended weight loss"]},
{"id":"rn-125","scope":["RN"],"name":{"generic":"Lisdexamfetamine","brand":["Vyvanse"]},"class":"CNS stimulant","mechanism":"Blocks the reuptake of norepinephrine and dopamine in specific areas of the brain","indications":["ADHD","Narcolepsy","Traumatic brain injury"],"contraindications":["Advanced arteriosclerosis","Symptomatic cardiovascular disease","Congenital cardiac structural abnormalities","Recent MI or angina","Severe hypertension","Heart failure","Arrhythmias","Hyperthyroidism","Glaucoma","History of substance use","History of psychiatric disorders","Tourette syndrome"],"interactions":["MAOIs or within 14 days","Alpha-1 adrenergic blockers","Phenytoin","Tricyclic antidepressants","Meperidine"],"education":["Report chest pain","Difficulty breathing","Fainting","Abnormal thinking or behavior","Increased aggression","Hallucinations","Unintended weight loss"]},
{"id":"rn-126","scope":["RN"],"name":{"generic":"Methamphetamine","brand":["Desoxyn"]},"class":"CNS stimulant","mechanism":"Blocks the reuptake of norepinephrine and dopamine in specific areas of the brain","indications":["ADHD","Narcolepsy","Traumatic brain injury"],"contraindications":["Advanced arteriosclerosis","Symptomatic cardiovascular disease","Congenital cardiac structural abnormalities","Recent MI or angina","Severe hypertension","Heart failure","Arrhythmias","Hyperthyroidism","Glaucoma","History of substance use","History of psychiatric disorders","Tourette syndrome"],"interactions":["MAOIs or within 14 days","Alpha-1 adrenergic blockers","Phenytoin","Tricyclic antidepressants","Meperidine"],"education":["Report chest pain","Difficulty breathing","Fainting","Abnormal thinking or behavior","Increased aggression","Hallucinations","Unintended weight loss"]},
{"id":"rn-127","scope":["RN"],"name":{"generic":"Dexmethylphenidate","brand":["Focalin"]},"class":"CNS stimulant","mechanism":"Blocks the reuptake of norepinephrine and dopamine in specific areas of the brain","indications":["ADHD","Narcolepsy","Traumatic brain injury"],"contraindications":["Advanced arteriosclerosis","Symptomatic cardiovascular disease","Congenital cardiac structural abnormalities","Recent MI or angina","Severe hypertension","Heart failure","Arrhythmias","Hyperthyroidism","Glaucoma","History of substance use","History of psychiatric disorders","Tourette syndrome"],"interactions":["MAOIs or within 14 days","Alpha-1 adrenergic blockers","Phenytoin","Tricyclic antidepressants","Meperidine"],"education":["Report chest pain","Difficulty breathing","Fainting","Abnormal thinking or behavior","Increased aggression","Hallucinations","Unintended weight loss"]},
{"id":"rn-128","scope":["RN"],"name":{"generic":"Serdexmethylphenidate and dexmethylphenidate","brand":["Azstarys"]},"class":"CNS stimulant","mechanism":"Blocks the reuptake of norepinephrine and dopamine in specific areas of the brain","indications":["ADHD","Narcolepsy","Traumatic brain injury"],"contraindications":["Advanced arteriosclerosis","Symptomatic cardiovascular disease","Congenital cardiac structural abnormalities","Recent MI or angina","Severe hypertension","Heart failure","Arrhythmias","Hyperthyroidism","Glaucoma","History of substance use","History of psychiatric disorders","Tourette syndrome"],"interactions":["MAOIs or within 14 days","Alpha-1 adrenergic blockers","Phenytoin","Tricyclic antidepressants","Meperidine"],"education":["Report chest pain","Difficulty breathing","Fainting","Abnormal thinking or behavior","Increased aggression","Hallucinations","Unintended weight loss"]},
{"id":"rn-129","scope":["RN"],"name":{"generic":"Modafinil","brand":["Provigil"]},"class":"CNS stimulant","mechanism":"Blocks the reuptake of norepinephrine and dopamine in specific areas of the brain","indications":["ADHD","Narcolepsy","Traumatic brain injury"],"contraindications":["Advanced arteriosclerosis","Symptomatic cardiovascular disease","Congenital cardiac structural abnormalities","Recent MI or angina","Severe hypertension","Heart failure","Arrhythmias","Hyperthyroidism","Glaucoma","History of substance use","History of psychiatric disorders","Tourette syndrome"],"interactions":["MAOIs or within 14 days","Alpha-1 adrenergic blockers","Phenytoin","Tricyclic antidepressants","Meperidine"],"education":["Report chest pain","Difficulty breathing","Fainting","Abnormal thinking or behavior","Increased aggression","Hallucinations","Unintended weight loss"]},
{"id":"rn-130","scope":["RN"],"name":{"generic":"Pitolisant","brand":["Wakix"]},"class":"CNS stimulant","mechanism":"Blocks the reuptake of norepinephrine and dopamine in specific areas of the brain","indications":["ADHD","Narcolepsy","Traumatic brain injury"],"contraindications":["Advanced arteriosclerosis","Symptomatic cardiovascular disease","Congenital cardiac structural abnormalities","Recent MI or angina","Severe hypertension","Heart failure","Arrhythmias","Hyperthyroidism","Glaucoma","History of substance use","History of psychiatric disorders","Tourette syndrome"],"interactions":["MAOIs or within 14 days","Alpha-1 adrenergic blockers","Phenytoin","Tricyclic antidepressants","Meperidine"],"education":["Report chest pain","Difficulty breathing","Fainting","Abnormal thinking or behavior","Increased aggression","Hallucinations","Unintended weight loss"]},
{"id":"rn-131","scope":["RN"],"name":{"generic":"Atomoxetine","brand":["Strattera"]},"class":"CNS nonstimulant, alpha-2 adrenergic agonist","mechanism":"Unknown","indications":["ADHD as monotherapy","ADHD as adjunct to a CNS stimulant"],"contraindications":["Hypersensitivity"],"interactions":["Tricyclic antidepressants","Antihypertensive agents","CNS depressants","Drugs affecting sinus node function or AV node conduction"],"education":["Report chest pain","Difficulty breathing","Fainting","Abnormal thinking or behavior","Increased aggression","Hallucinations","Unintended weight loss"]},
{"id":"rn-132","scope":["RN"],"name":{"generic":"Guanfacine","brand":["Intuniv"]},"class":"CNS nonstimulant, alpha-2 adrenergic agonist","mechanism":"Unknown","indications":["ADHD as monotherapy","ADHD as adjunct to a CNS stimulant"],"contraindications":["Hypersensitivity"],"interactions":["Tricyclic antidepressants","Antihypertensive agents","CNS depressants","Drugs affecting sinus node function or AV node conduction"],"education":["Report chest pain","Difficulty breathing","Fainting","Abnormal thinking or behavior","Increased aggression","Hallucinations","Unintended weight loss"]},
{"id":"rn-133","scope":["RN"],"name":{"generic":"Clonidine","brand":["Kapvay"]},"class":"CNS nonstimulant, alpha-2 adrenergic agonist","mechanism":"Unknown","indications":["ADHD as monotherapy","ADHD as adjunct to a CNS stimulant"],"contraindications":["Hypersensitivity"],"interactions":["Tricyclic antidepressants","Antihypertensive agents","CNS depressants","Drugs affecting sinus node function or AV node conduction"],"education":["Report chest pain","Difficulty breathing","Fainting","Abnormal thinking or behavior","Increased aggression","Hallucinations","Unintended weight loss"]},
{"id":"rn-134","scope":["RN"],"name":{"generic":"Viloxazine","brand":["Qelbree"]},"class":"CNS nonstimulant, alpha-2 adrenergic agonist","mechanism":"Unknown","indications":["ADHD as monotherapy","ADHD as adjunct to a CNS stimulant"],"contraindications":["Hypersensitivity"],"interactions":["Tricyclic antidepressants","Antihypertensive agents","CNS depressants","Drugs affecting sinus node function or AV node conduction"],"education":["Report chest pain","Difficulty breathing","Fainting","Abnormal thinking or behavior","Increased aggression","Hallucinations","Unintended weight loss"]},
{"id":"rn-135","scope":["RN"],"name":{"generic":"Solriamfetol","brand":["Sunosi"]},"class":"CNS nonstimulant, alpha-2 adrenergic agonist","mechanism":"Unknown","indications":["ADHD as monotherapy","ADHD as adjunct to a CNS stimulant"],"contraindications":["Hypersensitivity"],"interactions":["Tricyclic antidepressants","Antihypertensive agents","CNS depressants","Drugs affecting sinus node function or AV node conduction"],"education":["Report chest pain","Difficulty breathing","Fainting","Abnormal thinking or behavior","Increased aggression","Hallucinations","Unintended weight loss"]},
{"id":"rn-136","scope":["RN"],"name":{"generic":"Sodium oxybate","brand":["Lumryz"]},"class":"CNS nonstimulant, alpha-2 adrenergic agonist","mechanism":"Unknown","indications":["ADHD as monotherapy","ADHD as adjunct to a CNS stimulant"],"contraindications":["Hypersensitivity"],"interactions":["Tricyclic antidepressants","Antihypertensive agents","CNS depressants","Drugs affecting sinus node function or AV node conduction"],"education":["Report chest pain","Difficulty breathing","Fainting","Abnormal thinking or behavior","Increased aggression","Hallucinations","Unintended weight loss"]},
{"id":"rn-137","scope":["RN"],"name":{"generic":"Acetaminophen","brand":["Tylenol"]},"class":"Nonsteroidal anti-inflammatory drug (NSAID)","mechanism":"Inhibits the enzyme cyclooxygenase to decrease the production of inflammatory cytokines and reduce inflammation and pain","indications":["Temporarily relieves minor aches and pains","Temporarily reduces fever"],"contraindications":["Hypersensitivity","Aspirin-sensitive asthma","Allergic reaction to aspirin"],"interactions":["Angiotensin II receptor blockers","ACE inhibitors","Lithium","Warfarin"],"education":["Monitor for signs of bleeding such as black tarry stools, coffee-ground emesis, or blood-streaked sputum"]},
{"id":"rn-138","scope":["RN"],"name":{"generic":"Aspirin","brand":[]},"class":"Nonsteroidal anti-inflammatory drug (NSAID)","mechanism":"Inhibits the enzyme cyclooxygenase to decrease the production of inflammatory cytokines and reduce inflammation and pain","indications":["Temporarily relieves minor aches and pains","Temporarily reduces fever"],"contraindications":["Hypersensitivity","Aspirin-sensitive asthma","Allergic reaction to aspirin"],"interactions":["Angiotensin II receptor blockers","ACE inhibitors","Lithium","Warfarin"],"education":["Monitor for signs of bleeding such as black tarry stools, coffee-ground emesis, or blood-streaked sputum"]},
{"id":"rn-139","scope":["RN"],"name":{"generic":"Ibuprofen","brand":["Motrin"]},"class":"Nonsteroidal anti-inflammatory drug (NSAID)","mechanism":"Inhibits the enzyme cyclooxygenase to decrease the production of inflammatory cytokines and reduce inflammation and pain","indications":["Temporarily relieves minor aches and pains","Temporarily reduces fever"],"contraindications":["Hypersensitivity","Aspirin-sensitive asthma","Allergic reaction to aspirin"],"interactions":["Angiotensin II receptor blockers","ACE inhibitors","Lithium","Warfarin"],"education":["Monitor for signs of bleeding such as black tarry stools, coffee-ground emesis, or blood-streaked sputum"]},
{"id":"rn-140","scope":["RN"],"name":{"generic":"Naproxen sodium","brand":["Aleve"]},"class":"Nonsteroidal anti-inflammatory drug (NSAID)","mechanism":"Inhibits the enzyme cyclooxygenase to decrease the production of inflammatory cytokines and reduce inflammation and pain","indications":["Temporarily relieves minor aches and pains","Temporarily reduces fever"],"contraindications":["Hypersensitivity","Aspirin-sensitive asthma","Allergic reaction to aspirin"],"interactions":["Angiotensin II receptor blockers","ACE inhibitors","Lithium","Warfarin"],"education":["Monitor for signs of bleeding such as black tarry stools, coffee-ground emesis, or blood-streaked sputum"]},
{"id":"rn-141","scope":["RN"],"name":{"generic":"Tramadol","brand":["Ultram"]},"class":"Nonsteroidal anti-inflammatory drug (NSAID)","mechanism":"Inhibits the enzyme cyclooxygenase to decrease the production of inflammatory cytokines and reduce inflammation and pain","indications":["Temporarily relieves minor aches and pains","Temporarily reduces fever"],"contraindications":["Hypersensitivity","Aspirin-sensitive asthma","Allergic reaction to aspirin"],"interactions":["Angiotensin II receptor blockers","ACE inhibitors","Lithium","Warfarin"],"education":["Monitor for signs of bleeding such as black tarry stools, coffee-ground emesis, or blood-streaked sputum"]},  
{"id":"rn-142","scope":["RN"],"name":{"generic":"Codeine","brand":[]},"class":"Opioid analgesic","mechanism":"Activates opioid receptors to modulate and reduce incoming painful signals to reduce pain perception","indications":["Moderate to severe pain"],"contraindications":["Hypersensitivity","Respiratory depression","Severe asthma","Paralytic ileus","Children"],"interactions":["Alprazolam","Diphenhydramine","Cyclobenzaprine"],"education":["Risk for opioid addiction, abuse, and misuse; tolerance may require higher doses; addiction is compulsive opioid use."]},
{"id":"rn-143","scope":["RN"],"name":{"generic":"Fentanyl","brand":[]},"class":"Opioid analgesic","mechanism":"Activates opioid receptors to modulate and reduce incoming painful signals to reduce pain perception","indications":["Moderate to severe pain"],"contraindications":["Hypersensitivity","Respiratory depression","Severe asthma","Paralytic ileus"],"interactions":["Alprazolam","Diphenhydramine","Cyclobenzaprine"],"education":["Risk for opioid addiction, abuse, and misuse; tolerance may require higher doses; addiction is compulsive opioid use."]},
{"id":"rn-144","scope":["RN"],"name":{"generic":"Hydromorphone","brand":["Dilaudid"]},"class":"Opioid analgesic","mechanism":"Activates opioid receptors to modulate and reduce incoming painful signals to reduce pain perception","indications":["Moderate to severe pain"],"contraindications":["Hypersensitivity","Respiratory depression","Severe asthma","Paralytic ileus"],"interactions":["Alprazolam","Diphenhydramine","Cyclobenzaprine"],"education":["Risk for opioid addiction, abuse, and misuse; tolerance may require higher doses; addiction is compulsive opioid use."]},
{"id":"rn-145","scope":["RN"],"name":{"generic":"Meperidine","brand":["Demerol"]},"class":"Opioid analgesic","mechanism":"Activates opioid receptors to modulate and reduce incoming painful signals to reduce pain perception","indications":["Moderate to severe pain"],"contraindications":["Hypersensitivity","Respiratory depression","Severe asthma","Paralytic ileus","Poor renal function"],"interactions":["Alprazolam","Diphenhydramine","Cyclobenzaprine"],"education":["Risk for opioid addiction, abuse, and misuse; tolerance may require higher doses; addiction is compulsive opioid use."]},
{"id":"rn-146","scope":["RN"],"name":{"generic":"Methadone","brand":["Dolophine"]},"class":"Opioid analgesic","mechanism":"Activates opioid receptors to modulate and reduce incoming painful signals to reduce pain perception","indications":["Moderate to severe pain"],"contraindications":["Hypersensitivity","Respiratory depression","Severe asthma","Paralytic ileus"],"interactions":["Alprazolam","Diphenhydramine","Cyclobenzaprine"],"education":["Risk for opioid addiction, abuse, and misuse; tolerance may require higher doses; addiction is compulsive opioid use."]},
{"id":"rn-147","scope":["RN"],"name":{"generic":"Morphine","brand":["MS Contin"]},"class":"Opioid analgesic","mechanism":"Activates opioid receptors to modulate and reduce incoming painful signals to reduce pain perception","indications":["Moderate to severe pain"],"contraindications":["Hypersensitivity","Respiratory depression","Severe asthma","Paralytic ileus"],"interactions":["Alprazolam","Diphenhydramine","Cyclobenzaprine"],"education":["Risk for opioid addiction, abuse, and misuse; tolerance may require higher doses; addiction is compulsive opioid use."]},
{"id":"rn-148","scope":["RN"],"name":{"generic":"Oxycodone","brand":["Roxicodone"]},"class":"Opioid analgesic","mechanism":"Activates opioid receptors to modulate and reduce incoming painful signals to reduce pain perception","indications":["Moderate to severe pain"],"contraindications":["Hypersensitivity","Respiratory depression","Severe asthma","Paralytic ileus"],"interactions":["Alprazolam","Diphenhydramine","Cyclobenzaprine"],"education":["Risk for opioid addiction, abuse, and misuse; tolerance may require higher doses; addiction is compulsive opioid use."]},
{"id":"rn-149","scope":["RN"],"name":{"generic":"Naloxone hydrochloride","brand":["Narcan"]},"class":"Opioid antagonist","mechanism":"Competitively antagonizes opioid receptors to reverse the depressant effects of opioids","indications":["Opioid overdose"],"contraindications":["Hypersensitivity"],"interactions":["Opioid agonists"],"education":["Can be bought over the counter."]},
{"id":"rn-150","scope":["RN"],"name":{"generic":"Buprenorphine-naltrexone","brand":["Suboxone"]},"class":"Partial opioid agonist/opioid antagonist","mechanism":"Buprenorphine acts as a partial agonist at the mu opioid receptor; naloxone is an opioid antagonist that precipitates withdrawal in opioid-dependent individuals when administered parenterally","indications":["Maintenance treatment of opioid dependence"],"contraindications":["Hypersensitivity"],"interactions":["Benzodiazepines","Cytochrome P450 3A4 inhibitors","Cyclobenzaprine","Diphenhydramine"],"education":["Determine last opioid use prior to starting therapy to avoid precipitated withdrawal reactions."]}, 
{"id":"rn-151","scope":["RN"],"name":{"generic":"Nicotine","brand":["Nicoderm","Nicorette"]},"class":"Norepinephrine/dopamine reuptake inhibitor (NDRI)","mechanism":"Blocks the reuptake of norepinephrine and dopamine in the CNS","indications":["Smoking cessation"],"contraindications":[],"interactions":[],"education":["Monitor all sources of nicotine exposure and discontinue if the patient decides to begin using nicotine-containing products again."]},
{"id":"rn-152","scope":["RN"],"name":{"generic":"Bupropion","brand":["Zyban"]},"class":"Norepinephrine/dopamine reuptake inhibitor (NDRI)","mechanism":"Blocks the reuptake of norepinephrine and dopamine in the CNS","indications":["Smoking cessation"],"contraindications":["Hypersensitivity","Increased seizure risk","CNS infection","CNS tumor","Head injury","Anorexia nervosa","Bulimia nervosa"],"interactions":["Clopidogrel","Carbamazepine","Phenytoin","Haloperidol","Monoamine oxidase inhibitors","Levodopa","Digoxin"],"education":["Monitor all sources of nicotine exposure and discontinue if the patient decides to begin using nicotine-containing products again."]},
{"id":"rn-153","scope":["RN"],"name":{"generic":"Benazepril","brand":["Lotensin"]},"class":"Angiotensin-converting enzyme (ACE) inhibitor","mechanism":"Inhibits the enzyme that converts angiotensin I to angiotensin II, suppressing the renin-angiotensin-aldosterone system","indications":["Control of hypertension","Treatment of heart failure","Treatment of acute myocardial infarction"],"contraindications":["Hypersensitivity","History of ACE inhibitor–related angioedema","Hereditary or idiopathic angioedema","Pregnancy"],"interactions":["Aliskiren","Sacubitril/valsartan","NSAIDs including COX-2 inhibitors","Potassium-sparing diuretics","Lithium","Temsirolimus","Sirolimus","Everolimus"],"education":["Avoid foods high in potassium and salt substitutes; persistent cough may develop."]},
{"id":"rn-154","scope":["RN"],"name":{"generic":"Captopril","brand":["Capto"]},"class":"Angiotensin-converting enzyme (ACE) inhibitor","mechanism":"Inhibits the enzyme that converts angiotensin I to angiotensin II, suppressing the renin-angiotensin-aldosterone system","indications":["Control of hypertension","Treatment of heart failure","Treatment of acute myocardial infarction"],"contraindications":["Hypersensitivity","History of ACE inhibitor–related angioedema","Hereditary or idiopathic angioedema","Pregnancy"],"interactions":["Aliskiren","Sacubitril/valsartan","NSAIDs including COX-2 inhibitors","Potassium-sparing diuretics","Lithium","Temsirolimus","Sirolimus","Everolimus"],"education":["Avoid foods high in potassium and salt substitutes; persistent cough may develop."]},
{"id":"rn-155","scope":["RN"],"name":{"generic":"Enalapril","brand":["Vasotec"]},"class":"Angiotensin-converting enzyme (ACE) inhibitor","mechanism":"Inhibits the enzyme that converts angiotensin I to angiotensin II, suppressing the renin-angiotensin-aldosterone system","indications":["Control of hypertension","Treatment of heart failure","Treatment of acute myocardial infarction"],"contraindications":["Hypersensitivity","History of ACE inhibitor–related angioedema","Hereditary or idiopathic angioedema","Pregnancy"],"interactions":["Aliskiren","Sacubitril/valsartan","NSAIDs including COX-2 inhibitors","Potassium-sparing diuretics","Lithium","Temsirolimus","Sirolimus","Everolimus"],"education":["Avoid foods high in potassium and salt substitutes; persistent cough may develop."]},
{"id":"rn-156","scope":["RN"],"name":{"generic":"Lisinopril","brand":["Zestril"]},"class":"Angiotensin-converting enzyme (ACE) inhibitor","mechanism":"Inhibits the enzyme that converts angiotensin I to angiotensin II, suppressing the renin-angiotensin-aldosterone system","indications":["Control of hypertension","Treatment of heart failure","Treatment of acute myocardial infarction"],"contraindications":["Hypersensitivity","History of ACE inhibitor–related angioedema","Hereditary or idiopathic angioedema","Pregnancy"],"interactions":["Aliskiren","Sacubitril/valsartan","NSAIDs including COX-2 inhibitors","Potassium-sparing diuretics","Lithium","Temsirolimus","Sirolimus","Everolimus"],"education":["Avoid foods high in potassium and salt substitutes; persistent cough may develop."]},
{"id":"rn-157","scope":["RN"],"name":{"generic":"Candesartan","brand":["Atacand"]},"class":"Angiotensin II receptor blocker (ARB)","mechanism":"Blocks angiotensin II receptors to decrease vasoconstriction and lower blood pressure","indications":["Control of hypertension","Treatment of heart failure"],"contraindications":["Hypersensitivity","Concomitant use with aliskiren in diabetes mellitus","Pregnancy"],"interactions":["Aliskiren","Spironolactone","Triamterene","Amiloride","NSAIDs including COX-2 inhibitors","ACE inhibitors","Lithium","Potassium supplements","Salt substitutes"],"education":["Monitor blood pressure. Avoid foods high in potassium and salt substitutes."]},
{"id":"rn-158","scope":["RN"],"name":{"generic":"Losartan","brand":["Cozaar"]},"class":"Angiotensin II receptor blocker (ARB)","mechanism":"Blocks angiotensin II receptors to decrease vasoconstriction and lower blood pressure","indications":["Control of hypertension","Treatment of heart failure"],"contraindications":["Hypersensitivity","Concomitant use with aliskiren in diabetes mellitus","Pregnancy"],"interactions":["Aliskiren","Spironolactone","Triamterene","Amiloride","NSAIDs including COX-2 inhibitors","ACE inhibitors","Lithium","Potassium supplements","Salt substitutes"],"education":["Monitor blood pressure. Avoid foods high in potassium and salt substitutes."]},
{"id":"rn-159","scope":["RN"],"name":{"generic":"Telmisartan","brand":["Micardis"]},"class":"Angiotensin II receptor blocker (ARB)","mechanism":"Blocks angiotensin II receptors to decrease vasoconstriction and lower blood pressure","indications":["Control of hypertension","Treatment of heart failure"],"contraindications":["Hypersensitivity","Concomitant use with aliskiren in diabetes mellitus","Pregnancy"],"interactions":["Aliskiren","Spironolactone","Triamterene","Amiloride","NSAIDs including COX-2 inhibitors","ACE inhibitors","Lithium","Potassium supplements","Salt substitutes"],"education":["Monitor blood pressure. Avoid foods high in potassium and salt substitutes."]},
{"id":"rn-160","scope":["RN"],"name":{"generic":"Valsartan","brand":["Diovan"]},"class":"Angiotensin II receptor blocker (ARB)","mechanism":"Blocks angiotensin II receptors to decrease vasoconstriction and lower blood pressure","indications":["Control of hypertension","Treatment of heart failure"],"contraindications":["Hypersensitivity","Concomitant use with aliskiren in diabetes mellitus","Pregnancy"],"interactions":["Aliskiren","Spironolactone","Triamterene","Amiloride","NSAIDs including COX-2 inhibitors","ACE inhibitors","Lithium","Potassium supplements","Salt substitutes"],"education":["Monitor blood pressure. Avoid foods high in potassium and salt substitutes."]},
{"id":"rn-161","scope":["RN"],"name":{"generic":"Carvedilol","brand":["Coreg"]},"class":"Beta-adrenergic blocker","mechanism":"Blocks beta-1 receptors, decreasing heart rate, myocardial contractility, and blood pressure to reduce cardiac workload","indications":["Hypertension","Angina","Acute myocardial infarction","Heart failure"],"contraindications":["Hypersensitivity","AV block","Cardiogenic shock","Hypotension","Acute heart failure","Bradycardia","Sick sinus syndrome","Severe peripheral arterial disease"],"interactions":["Albuterol","Clonidine","Mefloquine","Calcium channel blockers","Ma-huang","Ephedra","Black cohosh","Hawthorne"],"education":["Check heart rate before taking; hold if pulse <60 bpm; do not stop medication abruptly."]},
{"id":"rn-162","scope":["RN"],"name":{"generic":"Nadolol","brand":["Corgard"]},"class":"Beta-adrenergic blocker","mechanism":"Blocks beta-1 receptors, reducing heart rate and blood pressure to decrease myocardial oxygen demand","indications":["Hypertension","Angina","Acute myocardial infarction","Heart failure"],"contraindications":["Hypersensitivity","AV block","Cardiogenic shock","Hypotension","Acute heart failure","Bradycardia","Sick sinus syndrome","Severe peripheral arterial disease"],"interactions":["Albuterol","Clonidine","Mefloquine","Calcium channel blockers","Ma-huang","Ephedra","Black cohosh","Hawthorne"],"education":["Monitor pulse and blood pressure; hold if HR <60 bpm; taper dose—do not discontinue abruptly."]},
{"id":"rn-163","scope":["RN"],"name":{"generic":"Amlodipine","brand":["Norvasc"]},"class":"Calcium channel blocker","mechanism":"Inhibits calcium ion influx into vascular smooth muscle, causing vasodilation and decreased peripheral vascular resistance","indications":["Hypertension","Angina"],"contraindications":["Hypersensitivity"],"interactions":["Simvastatin","Clarithromycin","Ritonavir"],"education":["Monitor blood pressure; take with food if GI upset occurs; report edema, dizziness, flushing, or severe headache."]},
{"id":"rn-164","scope":["RN"],"name":{"generic":"Nicardipine","brand":["Cardene"]},"class":"Calcium channel blocker","mechanism":"Blocks calcium entry into vascular smooth muscle, producing arterial vasodilation and reduced blood pressure","indications":["Hypertension","Angina"],"contraindications":["Hypersensitivity"],"interactions":["Simvastatin","Clarithromycin","Ritonavir"],"education":["Assess blood pressure and heart rate; take with food to minimize GI upset; report dizziness, flushing, headache, or peripheral edema."]},
{"id":"rn-165","scope":["RN"],"name":{"generic":"Nifedipine","brand":["Procardia"]},"class":"Calcium channel blocker","mechanism":"Inhibits calcium influx into vascular smooth muscle, decreasing systemic vascular resistance","indications":["Hypertension","Angina"],"contraindications":["Hypersensitivity"],"interactions":["Simvastatin","Clarithromycin","Ritonavir"],"education":["Monitor blood pressure and heart rate; report chest pain, palpitations, dizziness; increased risk of myocardial infarction, stroke, and dysrhythmias."]},
{"id":"rn-166","scope":["RN"],"name":{"generic":"Chlorthalidone","brand":["Thalitone"]},"class":"Thiazide-like diuretic","mechanism":"Inhibits sodium and chloride reabsorption in the distal convoluted tubule, increasing water excretion and lowering blood pressure","indications":["Hypertension","Edema"],"contraindications":["Anuria","Hypersensitivity"],"interactions":["Dofetilide","Antidiabetic drugs","Barbiturates","Cholestyramine","NSAIDs","Lithium"],"education":["Take in the morning; monitor daily weight; report weight gain >2 lb/day or >5 lb/week."]},
{"id":"rn-167","scope":["RN"],"name":{"generic":"Hydrochlorothiazide","brand":["Microzide"]},"class":"Thiazide diuretic","mechanism":"Blocks sodium and chloride reabsorption in the distal tubule, promoting diuresis and decreased blood pressure","indications":["Hypertension","Edema"],"contraindications":["Anuria","Hypersensitivity"],"interactions":["Dofetilide","Antidiabetic drugs","Barbiturates","Cholestyramine","NSAIDs","Lithium"],"education":["Administer early in the day; monitor weight and electrolytes; report rapid weight changes."]},
{"id":"rn-168","scope":["RN"],"name":{"generic":"Amiloride","brand":["Midamor"]},"class":"Potassium-sparing diuretic","mechanism":"Inhibits sodium reabsorption in the distal tubule while conserving potassium","indications":["Hypertension","Edema"],"contraindications":["Anuria","Hypersensitivity"],"interactions":["Dofetilide","Antidiabetic drugs","Barbiturates","Cholestyramine","NSAIDs","Lithium","Potassium supplements"],"education":["Take in the morning; monitor weight and potassium levels; report sudden weight changes."]},
{"id":"rn-169","scope":["RN"],"name":{"generic":"Spironolactone","brand":["Aldactone"]},"class":"Potassium-sparing diuretic","mechanism":"Antagonizes aldosterone in the distal nephron, promoting sodium and water excretion while retaining potassium","indications":["Hypertension","Edema"],"contraindications":["Anuria","Hypersensitivity"],"interactions":["Dofetilide","Antidiabetic drugs","Barbiturates","Cholestyramine","NSAIDs","Lithium","Potassium supplements"],"education":["Take in the morning; avoid potassium supplements; monitor daily weight and report rapid changes."]}, 
{"id":"rn-170","scope":["RN"],"name":{"generic":"Triamterene","brand":["Dyrenium"]},"class":"Potassium-sparing diuretic","mechanism":"Reduces sodium reabsorption in the distal tubule while conserving potassium","indications":["Hypertension","Edema"],"contraindications":["Anuria","Hypersensitivity"],"interactions":["Dofetilide","Antidiabetic drugs","Barbiturates","Cholestyramine","NSAIDs","Lithium","Potassium supplements"],"education":["Administer early in the day; monitor potassium and daily weight; report rapid weight gain or loss."]}, 
{"id":"rn-171","scope":["RN"],"name":{"generic":"Isosorbide dinitrate","brand":["Isordil"]},"class":"Nitrate","mechanism":"Relaxes vascular smooth muscle, causing vasodilation, reduced preload and afterload, and decreased cardiac workload","indications":["Angina","Acute coronary syndrome","Hypertension","Heart failure"],"contraindications":["Hypersensitivity","Increased intracranial pressure","Cardiomyopathy","Shock"],"interactions":["Avanafil","Riociguat","Sildenafil","Tadalafil","Vardenafil"],"education":["May cause headaches; monitor blood pressure; avoid erectile dysfunction medications due to risk of severe hypotension."]},
{"id":"rn-172","scope":["RN"],"name":{"generic":"Isosorbide mononitrate","brand":["Imdur"]},"class":"Nitrate","mechanism":"Causes smooth muscle relaxation and vasodilation, lowering cardiac workload and systemic vascular resistance","indications":["Angina","Acute coronary syndrome","Hypertension","Heart failure"],"contraindications":["Hypersensitivity","Increased intracranial pressure","Cardiomyopathy","Shock"],"interactions":["Avanafil","Riociguat","Sildenafil","Tadalafil","Vardenafil"],"education":["Monitor for headaches and hypotension; do not use with erectile dysfunction medications."]},
{"id":"rn-173","scope":["RN"],"name":{"generic":"Nitroglycerin","brand":["Nitrobid","Nitrostat","Nitrolingual"]},"class":"Nitrate","mechanism":"Dilates veins and arteries, decreasing cardiac workload, preload, and systemic vascular resistance","indications":["Angina","Hypertensive emergency","Pulmonary edema","Heart failure"],"contraindications":["Hypersensitivity","Increased intracranial pressure","Cardiomyopathy","Shock"],"interactions":["Avanafil","Riociguat","Sildenafil","Tadalafil","Vardenafil"],"education":["Monitor blood pressure; may cause headache; avoid erectile dysfunction medications."]},
{"id":"rn-174","scope":["RN"],"name":{"generic":"Nitroprusside","brand":["Nipride"]},"class":"Nitrate / Vasodilator","mechanism":"Directly relaxes vascular smooth muscle, causing arterial and venous dilation, lowering blood pressure and cardiac workload","indications":["Hypertensive emergencies","Heart failure","Acute coronary syndrome","Angina"],"contraindications":["Hypersensitivity","Increased intracranial pressure","Cardiomyopathy","Shock"],"interactions":["Avanafil","Riociguat","Sildenafil","Tadalafil","Vardenafil"],"education":["Monitor BP continuously; may cause headaches; avoid erectile dysfunction medications due to risk of severe hypotension."]},
{"id":"rn-175","scope":["RN"],"name":{"generic":"Sacubitril/valsartan","brand":["Entresto"]},"class":"Angiotensin receptor-neprilysin inhibitor (ARNI)","mechanism":"Blocks angiotensin II receptors and inhibits neprilysin, increasing natriuretic peptides and reducing cardiac workload","indications":["Heart failure"],"contraindications":["Pregnancy","History of angioedema with ACE inhibitor or ARB"],"interactions":["Potassium-sparing diuretics","NSAIDs","Lithium","ACE inhibitors"],"education":["Avoid potassium-rich foods and salt substitutes; report cough, angioedema, or signs of anaphylaxis."]},
{"id":"rn-176","scope":["RN"],"name":{"generic":"Eplerenone","brand":["Inspra"]},"class":"Mineralocorticoid receptor antagonist (MRA)","mechanism":"Blocks aldosterone at mineralocorticoid receptors in the nephron, promoting sodium and water excretion while conserving potassium","indications":["Heart failure","Hypertension","Edema associated with hepatic cirrhosis or nephrotic syndrome"],"contraindications":["Hyperkalemia","Addison’s disease","Pregnancy","Concurrent use of eplerenone"],"interactions":["Agents that increase potassium","Lithium","NSAIDs","Digoxin","Aspirin"],"education":["Monitor potassium levels closely; risk for hyperkalemia; report palpitations or muscle weakness."]},
{"id":"rn-177","scope":["RN"],"name":{"generic":"Dapagliflozin","brand":["Farxiga"]},"class":"Sodium-glucose cotransporter 2 (SGLT2) inhibitor","mechanism":"Inhibits SGLT2 in the proximal renal tubules, reducing glucose and sodium reabsorption and promoting glucosuria and diuresis","indications":["Heart failure","Type 2 diabetes mellitus"],"contraindications":["Hypersensitivity","Severe renal impairment, end-stage renal disease, or dialysis","Pregnancy"],"interactions":["Insulin","Lithium"],"education":["Monitor hydration and blood pressure; risk of hypotension with volume depletion; report dizziness or signs of dehydration."]}, 
{"id":"rn-178","scope":["RN"],"name":{"generic":"Empagliflozin","brand":["Jardiance"]},"class":"Sodium-glucose cotransporter 2 (SGLT2) inhibitor","mechanism":"Blocks SGLT2 in the proximal tubule, promoting glucose and sodium excretion, lowering blood glucose and reducing cardiac preload","indications":["Heart failure","Type 2 diabetes mellitus"],"contraindications":["Hypersensitivity","Severe renal impairment, end-stage renal disease, or dialysis","Pregnancy"],"interactions":["Insulin","Lithium"],"education":["Assess hydration and blood pressure; risk of hypotension with hypovolemia; report dizziness or excessive urination."]}, 
{"id":"rn-179","scope":["RN"],"name":{"generic":"Bumetanide","brand":["Bumex"]},"class":"Loop diuretic","mechanism":"Inhibits sodium and chloride reabsorption in the loop of Henle, promoting water excretion","indications":["Hypertension","Edema associated with heart failure"],"contraindications":["Anuria","Hypersensitivity"],"interactions":["Aminoglycosides"],"education":["Take in the morning; eat potassium-rich foods; monitor daily weight; report weight gain >2 lb/day or >5 lb/week."]},
{"id":"rn-180","scope":["RN"],"name":{"generic":"Furosemide","brand":["Lasix"]},"class":"Loop diuretic","mechanism":"Blocks sodium and chloride reabsorption in the loop of Henle, increasing urine output and lowering blood pressure","indications":["Hypertension","Edema associated with heart failure"],"contraindications":["Anuria","Hypersensitivity"],"interactions":["Aminoglycosides"],"education":["Administer early in the day; consume potassium-rich foods; monitor weight daily; report rapid weight changes."]},
{"id":"rn-181","scope":["RN"],"name":{"generic":"Torsemide","brand":["Demadex"]},"class":"Loop diuretic","mechanism":"Inhibits sodium and chloride reabsorption in the loop of Henle, promoting diuresis and reducing fluid overload","indications":["Hypertension","Edema associated with heart failure"],"contraindications":["Anuria","Hypersensitivity"],"interactions":["Aminoglycosides"],"education":["Take in the morning; eat potassium-rich foods; monitor daily weight; report weight gain >2 lb/day or >5 lb/week."]},
{"id":"rn-182","scope":["RN"],"name":{"generic":"Chlorothiazide","brand":["Diruil"]},"class":"Thiazide diuretic","mechanism":"Inhibits sodium and chloride reabsorption in the distal convoluted tubule, increasing water excretion and lowering blood pressure","indications":["Hypertension","Edema associated with heart failure"],"contraindications":["Anuria","Hypersensitivity"],"interactions":["Dofetilide","Antidiabetic drugs","Barbiturates","Cholestyramine","NSAIDs","Lithium"],"education":["Take early in the morning; monitor weight and electrolytes; report weight gain >2 lb/day or >5 lb/week."]},
{"id":"rn-183","scope":["RN"],"name":{"generic":"Indapamide","brand":["Lozol"]},"class":"Thiazide-like diuretic","mechanism":"Blocks sodium and chloride reabsorption in the distal convoluted tubule, increasing diuresis and lowering blood pressure","indications":["Hypertension","Edema associated with heart failure"],"contraindications":["Anuria","Hypersensitivity"],"interactions":["Dofetilide","Antidiabetic drugs","Barbiturates","Cholestyramine","NSAIDs","Lithium"],"education":["Administer early in the day; monitor weight and electrolytes; report rapid weight changes."]},
{"id":"rn-184","scope":["RN"],"name":{"generic":"Metolazone","brand":["Zaroxolyn"]},"class":"Thiazide-like diuretic","mechanism":"Inhibits sodium and chloride reabsorption in the distal convoluted tubule, promoting water excretion and lowering blood pressure","indications":["Hypertension","Edema associated with heart failure"],"contraindications":["Anuria","Hypersensitivity"],"interactions":["Dofetilide","Antidiabetic drugs","Barbiturates","Cholestyramine","NSAIDs","Lithium"],"education":["Take early in the morning; monitor weight and electrolytes; report weight gain >2 lb/day or >5 lb/week."]},
{"id":"rn-185","scope":["RN"],"name":{"generic":"Hydralazine and isosorbide dinitrate","brand":["BiDil"]},"class":"Arteriolar vasodilator / Nitrate vasodilator","mechanism":"Hydralazine relaxes arteriolar smooth muscle causing vasodilation; isosorbide dinitrate releases nitric oxide, promoting venous and arterial dilation and reducing cardiac workload","indications":["Adjunct treatment for heart failure in self-identified Black patients or those intolerant to standard therapy"],"contraindications":["Concurrent use of phosphodiesterase type 5 (PDE5) inhibitors"],"interactions":["Phosphodiesterase type 5 (PDE5) inhibitors"],"education":["Monitor blood pressure; risk for hypotension; do not use with erectile dysfunction medications."]},
{"id":"rn-186","scope":["RN"],"name":{"generic":"Ivabradine","brand":["Corlanor"]},"class":"If current inhibitor","mechanism":"Blocks hyperpolarization-activated cyclic nucleotide-gated (HCN) channels in the sinoatrial node, slowing heart rate without affecting contractility","indications":["Stable heart failure with ejection fraction ≤35% to reduce risk of hospitalization"],"contraindications":["Acute decompensated heart failure","Hypotension","History of conduction disorders","Bradycardia","Liver dysfunction","Pregnancy"],"interactions":["CYP450 inhibitors/inducers","Verapamil","Diltiazem"],"education":["Monitor heart rate; report dizziness, lightheadedness, or irregular heartbeat; avoid grapefruit juice."]},
{"id":"rn-187","scope":["RN"],"name":{"generic":"Heparin","brand":[]},"class":"Injectable anticoagulant","mechanism":"Potentiates antithrombin III, inactivating thrombin (IIa) and factor Xa","indications":["VTE/PE prophylaxis and treatment","ACS","Atrial fibrillation"],"contraindications":["Active bleeding","History of HIT"],"interactions":["NSAIDs","Antiplatelets","Other anticoagulants"],"education":["Monitor aPTT/anti-Xa","Watch for bleeding and HIT"]},
{"id":"rn-188","scope":["RN"],"name":{"generic":"Argatroban","brand":[]},"class":"Direct thrombin inhibitor","mechanism":"Directly inhibits thrombin (IIa)","indications":["Anticoagulation in HIT"],"contraindications":["Active bleeding","Severe hepatic impairment"],"interactions":["Other anticoagulants","Antiplatelets"],"education":["Monitor aPTT","Assess for bleeding"]},
{"id":"rn-189","scope":["RN"],"name":{"generic":"Bivalirudin","brand":["Angiomax"]},"class":"Direct thrombin inhibitor","mechanism":"Reversibly inhibits thrombin","indications":["PCI","HIT patients undergoing PCI"],"contraindications":["Active bleeding"],"interactions":["Other anticoagulants"],"education":["Monitor aPTT/ACT","Assess for bleeding"]},
{"id":"rn-190","scope":["RN"],"name":{"generic":"Enoxaparin","brand":["Lovenox"]},"class":"Low-molecular-weight heparin","mechanism":"Enhances antithrombin III, primarily inhibiting factor Xa","indications":["VTE prophylaxis and treatment","ACS"],"contraindications":["Active bleeding","History of HIT"],"interactions":["NSAIDs","Antiplatelets"],"education":["SubQ injection","Do not expel air bubble","Monitor for bleeding"]},
{"id":"rn-191","scope":["RN"],"name":{"generic":"Dalteparin","brand":["Fragmin"]},"class":"Low-molecular-weight heparin","mechanism":"Potentiates antithrombin III to inhibit factor Xa","indications":["VTE prophylaxis and treatment"],"contraindications":["Active bleeding","History of HIT"],"interactions":["NSAIDs","Antiplatelets"],"education":["SubQ injection","Monitor for bleeding"]},
{"id":"rn-192","scope":["RN"],"name":{"generic":"Warfarin","brand":["Coumadin"]},"class":"Vitamin K antagonist","mechanism":"Inhibits vitamin K epoxide reductase, decreasing factors II, VII, IX, X","indications":["Atrial fibrillation","Mechanical heart valves","VTE/PE"],"contraindications":["Pregnancy","Active bleeding"],"interactions":["Vitamin K foods","Antibiotics","Alcohol"],"education":["Monitor INR","Maintain consistent vitamin K intake"]},
{"id":"rn-193","scope":["RN"],"name":{"generic":"Apixaban","brand":["Eliquis"]},"class":"Direct factor Xa inhibitor","mechanism":"Selectively inhibits factor Xa","indications":["Stroke prevention in AF","VTE/PE"],"contraindications":["Active bleeding"],"interactions":["Strong CYP3A4/P-gp inhibitors"],"education":["No routine labs","Do not stop abruptly"]},
{"id":"rn-194","scope":["RN"],"name":{"generic":"Rivaroxaban","brand":["Xarelto"]},"class":"Direct factor Xa inhibitor","mechanism":"Inhibits factor Xa, reducing thrombin generation","indications":["Atrial fibrillation","VTE/PE"],"contraindications":["Active bleeding"],"interactions":["CYP3A4 inhibitors"],"education":["Take with food as prescribed","Monitor for bleeding"]},
{"id":"rn-195","scope":["RN"],"name":{"generic":"Edoxaban","brand":["Savaysa"]},"class":"Direct factor Xa inhibitor","mechanism":"Inhibits factor Xa","indications":["Atrial fibrillation","VTE"],"contraindications":["Active bleeding","CrCl >95 mL/min (AF)"],"interactions":["P-gp inhibitors"],"education":["Assess renal function","Monitor for bleeding"]},
{"id":"rn-196","scope":["RN"],"name":{"generic":"Dabigatran","brand":["Pradaxa"]},"class":"Direct thrombin inhibitor","mechanism":"Directly inhibits thrombin (IIa)","indications":["Atrial fibrillation","VTE/PE"],"contraindications":["Active bleeding","Mechanical heart valves"],"interactions":["P-gp inhibitors"],"education":["Swallow capsules whole","Monitor renal function"]},
{"id":"rn-197","scope":["RN"],"name":{"generic":"Protamine","brand":[]},"class":"Anticoagulant reversal agent","mechanism":"Binds and neutralizes heparin","indications":["Heparin reversal"],"contraindications":["Fish allergy","Prior protamine exposure"],"interactions":[],"education":["Slow IV push","Monitor for hypotension/anaphylaxis"]},
{"id":"rn-198","scope":["RN"],"name":{"generic":"Vitamin K","brand":["Phytonadione"]},"class":"Anticoagulant reversal agent","mechanism":"Restores synthesis of vitamin K–dependent clotting factors","indications":["Warfarin reversal"],"contraindications":["Hypersensitivity"],"interactions":["Warfarin"],"education":["High doses may cause warfarin resistance","Monitor INR"]},
{"id":"rn-199","scope":["RN"],"name":{"generic":"Aspirin","brand":[]},"class":"Antiplatelet","mechanism":"Inhibits COX-1 in platelets, decreasing thromboxane A2 and platelet aggregation","indications":["Primary and secondary prevention of cardiovascular disease","Acute coronary syndromes"],"contraindications":["Hypersensitivity","Active pathological bleeding"],"interactions":["NSAIDs","Warfarin","SSRIs","SNRIs","Other antiplatelet or anticoagulant agents"],"education":["Recognize signs and symptoms of bleeding"]},
{"id":"rn-200","scope":["RN"],"name":{"generic":"Clopidogrel","brand":["Plavix"]},"class":"Antiplatelet; P2Y12 inhibitor","mechanism":"Irreversibly inhibits platelet activation by blocking the P2Y12 ADP receptor","indications":["Acute coronary syndromes","Secondary prevention of MI and stroke","Peripheral artery disease"],"contraindications":["Hypersensitivity","Active pathological bleeding"],"interactions":["CYP2C19 inhibitors","NSAIDs","Warfarin","SSRIs","SNRIs","Other antiplatelet or anticoagulant agents","Repaglinide"],"education":["Recognize signs and symptoms of bleeding"]},
{"id":"rn-201","scope":["RN"],"name":{"generic":"Prasugrel","brand":["Effient"]},"class":"Antiplatelet; P2Y12 inhibitor","mechanism":"Irreversibly inhibits platelet activation by blocking the P2Y12 ADP receptor","indications":["Acute coronary syndromes","Prevention of MI and stroke"],"contraindications":["Hypersensitivity","Active pathological bleeding"],"interactions":["NSAIDs","Warfarin","SSRIs","SNRIs","Other antiplatelet or anticoagulant agents"],"education":["Recognize signs and symptoms of bleeding"]},
{"id":"rn-202","scope":["RN"],"name":{"generic":"Ticagrelor","brand":["Brilinta"]},"class":"Antiplatelet; P2Y12 inhibitor","mechanism":"Reversibly inhibits platelet activation by blocking the P2Y12 ADP receptor","indications":["Acute coronary syndromes","Prevention of MI and stroke"],"contraindications":["Hypersensitivity","Active pathological bleeding"],"interactions":["NSAIDs","Warfarin","SSRIs","SNRIs","Other antiplatelet or anticoagulant agents"],"education":["Recognize signs and symptoms of bleeding"]},
{"id":"rn-203","scope":["RN"],"name":{"generic":"Cangrelor","brand":["Kengreal"]},"class":"Antiplatelet; P2Y12 inhibitor","mechanism":"Reversibly inhibits platelet activation by blocking the P2Y12 ADP receptor","indications":["Acute coronary syndromes","Percutaneous coronary intervention"],"contraindications":["Hypersensitivity","Active pathological bleeding"],"interactions":["NSAIDs","Warfarin","Other antiplatelet or anticoagulant agents"],"education":["Recognize signs and symptoms of bleeding"]},
{"id":"rn-204","scope":["RN"],"name":{"generic":"Eptifibatide","brand":["Integrilin"]},"class":"Antiplatelet; GP IIb/IIIa inhibitor","mechanism":"Blocks glycoprotein IIb/IIIa receptors, preventing platelet aggregation","indications":["Acute coronary syndromes","Percutaneous coronary intervention"],"contraindications":["Hypersensitivity","Active pathological bleeding"],"interactions":["NSAIDs","Warfarin","Other antiplatelet or anticoagulant agents"],"education":["Recognize signs and symptoms of bleeding"]},
{"id":"rn-205","scope":["RN"],"name":{"generic":"Alteplase","brand":["Activase","Cathflo Activase"]},"class":"Thrombolytic","mechanism":"Converts plasminogen to plasmin, which breaks down clot-bound fibrin","indications":["Acute ischemic stroke","Acute myocardial infarction","Acute massive pulmonary embolism"],"contraindications":["Active internal bleeding","Recent intracranial or intraspinal surgery or serious head trauma","Intracranial conditions increasing bleeding risk","Severe uncontrolled hypertension","Current intracranial hemorrhage","Subarachnoid hemorrhage","Recent stroke (for MI or PE)"],"interactions":["Anticoagulants","Antiplatelets","ACE inhibitors"],"education":["Use a dedicated IV line","Recognize signs and symptoms of bleeding"]},
{"id":"rn-206","scope":["RN"],"name":{"generic":"Tenecteplase","brand":["TNKase"]},"class":"Thrombolytic","mechanism":"Converts plasminogen to plasmin, which breaks down clot-bound fibrin","indications":["Acute ischemic stroke","Acute myocardial infarction","Acute massive pulmonary embolism"],"contraindications":["Active internal bleeding","Recent intracranial or intraspinal surgery or serious head trauma","Intracranial conditions increasing bleeding risk","Severe uncontrolled hypertension","Current intracranial hemorrhage","Subarachnoid hemorrhage","Recent stroke (for MI or PE)"],"interactions":["Anticoagulants","Antiplatelets","ACE inhibitors"],"education":["Use a dedicated IV line","Recognize signs and symptoms of bleeding"]},
{"id":"rn-207","scope":["RN"],"name":{"generic":"Atorvastatin","brand":["Lipitor"]},"class":"Statin","mechanism":"Inhibits HMG-CoA reductase, decreasing hepatic cholesterol synthesis","indications":["Reduction of cardiovascular risk","Primary hyperlipidemia","Familial hypercholesterolemia","Primary dysbetaliproteinemia","Hypertriglyceridemia"],"contraindications":["Acute liver failure","Decompensated cirrhosis","Hypersensitivity"],"interactions":["Rifampin","Oral contraceptives","Digoxin","Amiodarone"],"education":["Report signs and symptoms of myositis or rhabdomyolysis"]},
{"id":"rn-208","scope":["RN"],"name":{"generic":"Fluvastatin","brand":["Lescol XL"]},"class":"Statin","mechanism":"Inhibits HMG-CoA reductase, decreasing hepatic cholesterol synthesis","indications":["Reduction of cardiovascular risk","Primary hyperlipidemia","Familial hypercholesterolemia","Primary dysbetaliproteinemia","Hypertriglyceridemia"],"contraindications":["Acute liver failure","Decompensated cirrhosis","Hypersensitivity"],"interactions":["Rifampin","Oral contraceptives","Digoxin","Amiodarone"],"education":["Report signs and symptoms of myositis or rhabdomyolysis"]},
{"id":"rn-209","scope":["RN"],"name":{"generic":"Pitavastatin","brand":["Livalo"]},"class":"Statin","mechanism":"Inhibits HMG-CoA reductase, decreasing hepatic cholesterol synthesis","indications":["Reduction of cardiovascular risk","Primary hyperlipidemia","Familial hypercholesterolemia","Primary dysbetaliproteinemia","Hypertriglyceridemia"],"contraindications":["Acute liver failure","Decompensated cirrhosis","Hypersensitivity"],"interactions":["Rifampin","Oral contraceptives","Digoxin","Amiodarone"],"education":["Report signs and symptoms of myositis or rhabdomyolysis"]},
{"id":"rn-210","scope":["RN"],"name":{"generic":"Pravastatin","brand":["Pravachol"]},"class":"Statin","mechanism":"Inhibits HMG-CoA reductase, decreasing hepatic cholesterol synthesis","indications":["Reduction of cardiovascular risk","Primary hyperlipidemia","Familial hypercholesterolemia","Primary dysbetaliproteinemia","Hypertriglyceridemia"],"contraindications":["Acute liver failure","Decompensated cirrhosis","Hypersensitivity"],"interactions":["Rifampin","Oral contraceptives","Digoxin","Amiodarone"],"education":["Report signs and symptoms of myositis or rhabdomyolysis"]},
{"id":"rn-211","scope":["RN"],"name":{"generic":"Rosuvastatin","brand":["Crestor"]},"class":"Statin","mechanism":"Inhibits HMG-CoA reductase, decreasing hepatic cholesterol synthesis","indications":["Reduction of cardiovascular risk","Primary hyperlipidemia","Familial hypercholesterolemia","Primary dysbetaliproteinemia","Hypertriglyceridemia"],"contraindications":["Acute liver failure","Decompensated cirrhosis","Hypersensitivity"],"interactions":["Rifampin","Oral contraceptives","Digoxin","Amiodarone"],"education":["Report signs and symptoms of myositis or rhabdomyolysis"]},
{"id":"rn-212","scope":["RN"],"name":{"generic":"Simvastatin","brand":["Zocor"]},"class":"Statin","mechanism":"Inhibits HMG-CoA reductase, decreasing hepatic cholesterol synthesis","indications":["Reduction of cardiovascular risk","Primary hyperlipidemia","Familial hypercholesterolemia","Primary dysbetaliproteinemia","Hypertriglyceridemia"],"contraindications":["Acute liver failure","Decompensated cirrhosis","Hypersensitivity"],"interactions":["Rifampin","Oral contraceptives","Digoxin","Amiodarone"],"education":["Report signs and symptoms of myositis or rhabdomyolysis"]},
{"id":"rn-213","scope":["RN"],"name":{"generic":"Alirocumab","brand":["Praluent"]},"class":"PCSK9 inhibitor","mechanism":"Binds to PCSK9, preventing LDL receptor degradation and increasing LDL clearance","indications":["Reduction of cardiovascular risk","Primary hyperlipidemia","Familial hypercholesterolemia"],"contraindications":["Hypersensitivity"],"interactions":["Minimal interaction risk"],"education":["Report unexplained muscle pain or weakness"]},
{"id":"rn-214","scope":["RN"],"name":{"generic":"Evolocumab","brand":["Repatha"]},"class":"PCSK9 inhibitor","mechanism":"Binds to PCSK9, preventing LDL receptor degradation and increasing LDL clearance","indications":["Reduction of cardiovascular risk","Primary hyperlipidemia","Familial hypercholesterolemia"],"contraindications":["Hypersensitivity"],"interactions":["Minimal interaction risk"],"education":["Report unexplained muscle pain or weakness"]},
{"id":"rn-215","scope":["RN"],"name":{"generic":"Inclisiran","brand":["Leqvio"]},"class":"Antilipemic agent; siRNA","mechanism":"Prevents hepatic synthesis of PCSK9 via RNA interference","indications":["Reduction of cardiovascular risk","Primary hyperlipidemia","Familial hypercholesterolemia"],"contraindications":["Hypersensitivity","Acute liver failure","Decompensated cirrhosis"],"interactions":["Minimal interaction risk"],"education":["Administer subcutaneously with initial dose, repeat at 3 months, then every 6 months"]},
{"id":"rn-216","scope":["RN"],"name":{"generic":"Cholestyramine","brand":["Questran"]},"class":"Bile acid sequestrant","mechanism":"Binds bile acids in the intestine, reducing absorption and decreasing available bile acids","indications":["Primary hyperlipidemia","Slow or reverse coronary atherosclerosis","Pruritus from partial biliary obstruction"],"contraindications":["Complete biliary obstruction"],"interactions":["Levothyroxine","Warfarin","Digoxin","Statins","Iron supplements","Fibric acid"],"education":["Give other medications 1 hour before or 4-6 hours after cholestyramine"]},
{"id":"rn-217","scope":["RN"],"name":{"generic":"Colesevelam","brand":["Welchol"]},"class":"Bile acid sequestrant","mechanism":"Binds bile acids in the intestine, reducing absorption and decreasing available bile acids","indications":["Primary hyperlipidemia","Pediatric heterozygous familial hypercholesterolemia (age 10–17)","Blood sugar reduction in type 2 diabetes"],"contraindications":["Complete biliary obstruction"],"interactions":["Levothyroxine","Warfarin","Digoxin","Statins","Iron supplements","Fibric acid"],"education":["Give other medications 1 hour before or 4-6 hours after colesevelam"]},
{"id":"rn-218","scope":["RN"],"name":{"generic":"Colestipol","brand":["Colestid"]},"class":"Bile acid sequestrant","mechanism":"Binds bile acids in the intestine, reducing absorption and decreasing available bile acids","indications":["Primary hyperlipidemia"],"contraindications":["Complete biliary obstruction"],"interactions":["Levothyroxine","Warfarin","Digoxin","Statins","Iron supplements","Fibric acid"],"education":["Give other medications 1 hour before or 4-6 hours after colestipol"]},
{"id":"rn-219","scope":["RN"],"name":{"generic":"Fenofibrate","brand":["Tricor"]},"class":"Fibric acid","mechanism":"Activates PPARs to increase triglyceride breakdown","indications":["Hypertriglyceridemia"],"contraindications":["Severe renal dysfunction including dialysis","Active liver disease","Gallbladder disease","Hypersensitivity","Lactation"],"interactions":["Warfarin","Immunosuppressants","Bile acid sequestrants","Colchicine","Statins"],"education":["Report signs and symptoms of muscle-related adverse effects"]},
{"id":"rn-220","scope":["RN"],"name":{"generic":"Gemfibrozil","brand":["Lopid"]},"class":"Fibric acid","mechanism":"Activates PPARs to increase triglyceride breakdown","indications":["Hypertriglyceridemia"],"contraindications":["Severe renal dysfunction including dialysis","Active liver disease","Gallbladder disease","Hypersensitivity","Lactation"],"interactions":["Warfarin","Immunosuppressants","Bile acid sequestrants","Colchicine","Statins"],"education":["Report signs and symptoms of muscle-related adverse effects"]},
{"id":"rn-221","scope":["RN"],"name":{"generic":"Niacin","brand":["Vitamin B3"]},"class":"Water-soluble vitamin","mechanism":"May increase lipoprotein lipase activity or enhance removal and reduce synthesis of LDL-cholesterol","indications":["Hyperlipidemia","Dyslipidemia","Hypertriglyceridemia"],"contraindications":["Active liver disease","Unexplained/persistent elevations in hepatic transaminases","Active peptic ulcer disease","Arterial bleeding","Hypersensitivity"],"interactions":["Minimal interaction risk"],"education":["Avoid using flush-free niacin for lipid management"]},
{"id":"rn-222","scope":["RN"],"name":{"generic":"Ezetimibe","brand":["Zetia"]},"class":"Cholesterol absorption inhibitor","mechanism":"Inhibits the Niemann-Pick C1-Like 1 cholesterol transporter, reducing intestinal cholesterol absorption","indications":["Primary hypercholesterolemia","Homozygous familial hypercholesterolemia","Homozygous sitosterolemia"],"contraindications":["Active liver disease including unexplained persistent elevations in hepatic transaminases","Pregnancy or possible pregnancy","Lactation","Hypersensitivity"],"interactions":["Cyclosporine","Fenofibrate/fibrates","Cholestyramine"],"education":["Monitor hepatic transaminase levels","Monitor for muscle-related events if combined with statins"]},
{"id":"rn-223","scope":["RN"],"name":{"generic":"Epinephrine","brand":["Adrenalin","EpiPen"]},"class":"Adrenergic agonist (nonselective)","mechanism":"Binds to alpha- and beta-adrenergic receptors, stimulating the sympathetic nervous system, increasing heart rate, blood pressure, and bronchodilation","indications":["Anaphylaxis","Ventricular fibrillation","Pulseless VT","Asystole","Pulseless electrical activity"],"contraindications":["Cardiac dilation","Coronary artery insufficiency","Shock during general anesthesia"],"interactions":["Other sympathomimetics","Digoxin","Tricyclic antidepressants","Antihistamines","Sodium L-thyroxine","Beta-blockers","Rapidly acting nitrates or alpha-blockers","MAO inhibitors"],"education":["Continuous cardiac monitoring required","Monitor BP, HR, rhythm","Assess for extravasation"]},
{"id":"rn-224","scope":["RN"],"name":{"generic":"Dopamine","brand":["Intropin"]},"class":"Inotrope","mechanism":"Stimulates dopaminergic, beta-1, and alpha receptors depending on dose, increasing cardiac output and vasoconstriction","indications":["Hypotension","Shock"],"contraindications":["Pheochromocytoma","Uncorrected tachyarrhythmias","Ventricular fibrillation","Hypersensitivity to metabisulfite"],"interactions":["MAO inhibitors","Tricyclic antidepressants","Beta-blockers","Alpha-blockers","Haloperidol","Cyclopropane or halogenated anesthetics","Other vasopressors or oxytocic drugs","Phenytoin"],"education":["Continuous cardiac monitoring required","Monitor BP, urine output, peripheral perfusion","Risk of peripheral ischemia in vascular disease"]},
{"id":"rn-225","scope":["RN"],"name":{"generic":"Dobutamine","brand":["Dobutrex"]},"class":"Inotrope","mechanism":"Directly stimulates beta-1 receptors, increasing contractility and heart rate","indications":["Short-term inotropic support for cardiac decompensation"],"contraindications":["Idiopathic hypertrophic subaortic stenosis","Hypersensitivity to bisulfite"],"interactions":["Beta-blockers","Sodium bicarbonate","Alkaline solutions"],"education":["Continuous cardiac monitoring required","Do not mix with other IV drugs","Monitor HR, BP, and cardiac output"]},
{"id":"rn-226","scope":["RN"],"name":{"generic":"Albuterol","brand":["ProAir HFA","Ventolin HFA"]},"class":"Beta-adrenergic receptor agonist","mechanism":"Directly stimulates beta receptors in the lungs, causing smooth muscle dilation and airway opening","indications":["Relief of bronchospasm"],"contraindications":["Hypersensitivity"],"interactions":["Other short-acting sympathomimetic aerosol bronchodilators","Epinephrine","MAO inhibitors","Tricyclic antidepressants","Beta-blockers"],"education":["May cause paradoxical bronchospasm, tachycardia, or immediate hypersensitivity reaction","Monitor respiratory status and heart rate"]},
{"id":"rn-227","scope":["RN"],"name":{"generic":"Norepinephrine","brand":["Levophed"]},"class":"Alpha/beta agonist","mechanism":"Stimulates alpha- and beta-adrenergic receptors, increasing blood pressure, heart rate, and contractility","indications":["Severe acute hypotension","Shock"],"contraindications":[],"interactions":["MAO inhibitors","Tricyclic antidepressants","Halogenated anesthetics"],"education":["Continuous cardiac monitoring required","Extravasation can cause tissue necrosis","Monitor BP, HR, and perfusion"]},
{"id":"rn-228","scope":["RN"],"name":{"generic":"Diphenhydramine","brand":["Benadryl"]},"class":"Antihistamine, first generation","mechanism":"Antagonizes histamine H1 receptor sites, hindering histamine effects","indications":["Rhinitis","Allergy symptoms","Motion sickness","Nighttime sleep aid"],"contraindications":["Hypersensitivity"],"interactions":["Other CNS depressants","MAO inhibitors"],"education":["Avoid in older clients due to anticholinergic effects","May increase risk of dementia","Reduced clearance in advanced age"]},
{"id":"rn-229","scope":["RN"],"name":{"generic":"Cetirizine","brand":["Zyrtec"]},"class":"Antihistamine, second generation","mechanism":"Blocks histamine at H1 receptor sites","indications":["Allergic rhinitis","Itching due to hives (urticaria)"],"contraindications":["Hypersensitivity"],"interactions":["Ketoconazole","Macrolide antibiotics"],"education":["Can cause drowsiness, sedation, dry mouth, and insomnia"]},
{"id":"rn-230","scope":["RN"],"name":{"generic":"Levocetirizine","brand":["Xyzal"]},"class":"Antihistamine, second generation","mechanism":"Blocks histamine at H1 receptor sites","indications":["Allergic rhinitis","Itching due to hives (urticaria)"],"contraindications":["Hypersensitivity"],"interactions":["Ketoconazole","Macrolide antibiotics"],"education":["Can cause drowsiness, sedation, dry mouth, and insomnia"]},
{"id":"rn-231","scope":["RN"],"name":{"generic":"Loratadine","brand":["Claritin"]},"class":"Antihistamine, second generation","mechanism":"Blocks histamine at H1 receptor sites","indications":["Allergic rhinitis","Itching due to hives (urticaria)"],"contraindications":["Hypersensitivity"],"interactions":["Ketoconazole","Macrolide antibiotics"],"education":["Can cause drowsiness, sedation, dry mouth, and insomnia"]},
{"id":"rn-232","scope":["RN"],"name":{"generic":"Fexofenadine","brand":["Allegra"]},"class":"Antihistamine, third generation","mechanism":"Inhibits peripheral H1 receptors","indications":["Seasonal allergies","Chronic idiopathic urticaria"],"contraindications":["Hypersensitivity"],"interactions":["Aluminum or magnesium antacids","Erythromycin","Ketoconazole","Rifampin"],"education":["Can cause fatigue, dizziness, nausea, and insomnia"]},
{"id":"rn-233","scope":["RN"],"name":{"generic":"Desloratadine","brand":["Clarinex"]},"class":"Antihistamine, third generation","mechanism":"Inhibits peripheral H1 receptors","indications":["Seasonal allergies","Chronic idiopathic urticaria"],"contraindications":["Hypersensitivity"],"interactions":["Aluminum or magnesium antacids","Erythromycin","Ketoconazole","Rifampin"],"education":["Can cause fatigue, dizziness, nausea, and insomnia"]},
{"id":"rn-234","scope":["RN"],"name":{"generic":"Oxymetazoline","brand":["Afrin"]},"class":"Nasal decongestant","mechanism":"Causes vasoconstriction of nasal mucosa to relieve congestion","indications":["Nasal congestion from colds, allergies, or respiratory conditions"],"contraindications":["Hypersensitivity"],"interactions":["Albuterol","Bupropion"],"education":["Rebound congestion if used >3 days","Use nasal spray as directed"]},
{"id":"rn-235","scope":["RN"],"name":{"generic":"Pseudoephedrine","brand":["Sudafed"]},"class":"Systemic nasal decongestant","mechanism":"Acts on adrenergic receptors to produce vasoconstriction, shrinking nasal mucosa","indications":["Relief of nasal congestion from colds, flu, or allergies"],"contraindications":["Hypersensitivity"],"interactions":["Metoprolol","Albuterol","Metformin","Guaifenesin","MAO inhibitors"],"education":["Report if symptoms not relieved within 1 week","Monitor BP in hypertensive patients"]},
{"id":"rn-236","scope":["RN"],"name":{"generic":"Phenylephrine","brand":["Sudafed PE"]},"class":"Systemic nasal decongestant","mechanism":"Acts on adrenergic receptors to produce vasoconstriction, shrinking nasal mucosa","indications":["Relief of nasal congestion from colds, flu, or allergies"],"contraindications":["Hypersensitivity"],"interactions":["Metoprolol","Albuterol","Metformin","Guaifenesin","MAO inhibitors"],"education":["Used in patients with high blood pressure","Report if symptoms not relieved within 1 week"]},
{"id":"rn-237","scope":["RN"],"name":{"generic":"Codeine/Guaifenesin","brand":["Robitussin AC"]},"class":"Opioid antitussive","mechanism":"Acts on the cough center in the medulla to suppress the cough reflex","indications":["Nonproductive cough, especially chronic"],"contraindications":["Hypersensitivity"],"interactions":["Other CNS depressants","Benzodiazepines","Bupropion","Macrolide antibiotics","Muscle relaxers","Serotonergic drugs","St. John's wort"],"education":["Report cough lasting >1 week or with other symptoms","Use caution due to opioid effects"]},
{"id":"rn-238","scope":["RN"],"name":{"generic":"Benzonatate","brand":["Tessalon"]},"class":"Nonopioid antitussive","mechanism":"Thought to act on the brainstem site that gates the cough reflex","indications":["Nonproductive coughs"],"contraindications":["Hypersensitivity","Children under 4 years"],"interactions":["MAOIs"],"education":["Report cough lasting >1 week or with other symptoms","Do not chew or dissolve capsules"]},
{"id":"rn-239","scope":["RN"],"name":{"generic":"Dextromethorphan","brand":["Robitussin"]},"class":"Nonopioid antitussive","mechanism":"Thought to act on the brainstem site that gates the cough reflex","indications":["Nonproductive coughs"],"contraindications":["Hypersensitivity","Children under 4 years"],"interactions":["MAOIs"],"education":["Report cough lasting >1 week or with other symptoms","Avoid exceeding recommended dose"]},
{"id":"rn-240","scope":["RN"],"name":{"generic":"Guaifenesin","brand":["Mucinex"]},"class":"Expectorant","mechanism":"Increases production of respiratory tract fluids to liquefy mucus","indications":["Productive coughs where airway clearance of mucus is needed"],"contraindications":["Hypersensitivity","Children under 12"],"interactions":["Cimetidine","Naltrexone"],"education":["Increase fluids to help loosen secretions","Report if cough persists or worsens"]},
{"id":"rn-241","scope":["RN"],"name":{"generic":"Acetylcysteine","brand":["Mucomyst"]},"class":"Mucolytic","mechanism":"Reduces viscosity of pulmonary secretions","indications":["Adjunctive therapy for pneumonia, bronchitis, and cystic fibrosis"],"contraindications":["Peptic ulcer disease","Esophageal varices","Mallory-Weis tears","Hypersensitivity"],"interactions":["Activated charcoal"],"education":["Report if symptoms last >1 week, worsen, or are accompanied by other symptoms","Use as directed for pulmonary conditions"]},
{"id":"rn-242","scope":["RN"],"name":{"generic":"Dornase alfa","brand":["Pulmozyme"]},"class":"Mucolytic","mechanism":"Reduces viscosity of pulmonary secretions","indications":["Adjunctive therapy for pneumonia, bronchitis, and cystic fibrosis"],"contraindications":["Peptic ulcer disease","Hypersensitivity"],"interactions":["Activated charcoal"],"education":["Report if symptoms last >1 week, worsen, or are accompanied by other symptoms","Use as directed for pulmonary conditions"]},
{"id":"rn-243","scope":["RN"],"name":{"generic":"Levalbuterol","brand":["Xopenex"]},"class":"Beta adrenergic","mechanism":"Relaxes bronchial, uterine, and vascular smooth muscle by stimulating beta-2 receptors","indications":["Prevention and relief of bronchospasm","Prevention of exercise-induced bronchospasm"],"contraindications":["Hypersensitivity"],"interactions":["Antiarrhythmics","Beta blockers","CNS stimulants"],"education":["Report worsening symptoms including shortness of breath, cough, chest tightness, and wheezing"]},
{"id":"rn-244","scope":["RN"],"name":{"generic":"Salmeterol","brand":["Serevent"]},"class":"Beta adrenergic","mechanism":"Relaxes bronchial, uterine, and vascular smooth muscle by stimulating beta-2 receptors","indications":["Prevention and relief of bronchospasm","Prevention of exercise-induced bronchospasm"],"contraindications":["Hypersensitivity"],"interactions":["Antiarrhythmics","Beta blockers","CNS stimulants"],"education":["Report worsening symptoms including shortness of breath, cough, chest tightness, and wheezing"]},
{"id":"rn-245","scope":["RN"],"name":{"generic":"Ephedrine","brand":["Emerphed"]},"class":"Alpha/beta adrenergic agonist","mechanism":"Relaxes bronchial smooth muscle by stimulating beta-2 receptors and stimulates alpha- and beta-adrenergic receptors in the sympathetic nervous system","indications":["Mild intermittent asthma"],"contraindications":["Angle-closure glaucoma","Heart failure","Intermittent asthma","Cardiovascular disease","Hypertension","Stroke"],"interactions":["Alpha blockers","Beta blockers","Cardiac glycosides","MAOIs"],"education":["Can cause increased heart rate and blood pressure, insomnia, and tremors","Report worsening respiratory symptoms"]},
{"id":"rn-246","scope":["RN"],"name":{"generic":"Ipratropium bromide","brand":["Atrovent"]},"class":"Anticholinergic","mechanism":"Inhibits vagally mediated reflexes by antagonizing acetylcholine at muscarinic receptors on bronchial smooth muscle","indications":["Bronchospasm","Relief of acute asthmatic symptoms when combined with albuterol"],"contraindications":["Hypersensitivity"],"interactions":["Other anticholinergics"],"education":["Report worsening symptoms including shortness of breath, cough, chest tightness, and wheezing"]},
{"id":"rn-247","scope":["RN"],"name":{"generic":"Tiotropium","brand":["Spiriva"]},"class":"Anticholinergic","mechanism":"Inhibits vagally mediated reflexes by antagonizing acetylcholine at muscarinic receptors on bronchial smooth muscle","indications":["Bronchospasm"],"contraindications":["Hypersensitivity"],"interactions":["Other anticholinergics"],"education":["Report worsening symptoms including shortness of breath, cough, chest tightness, and wheezing"]},
{"id":"rn-248","scope":["RN"],"name":{"generic":"Beclomethasone","brand":["Qvar"]},"class":"Corticosteroid","mechanism":"Anti-inflammatory effects by stabilizing leukocyte lysosomal membranes, suppressing immune response, stimulating bone marrow activity, and affecting protein, fat, and carbohydrate metabolism","indications":["Asthmatic conditions","COPD"],"contraindications":["Hypersensitivity"],"interactions":["Antidiabetic drugs","NSAIDs","Cyclosporine"],"education":["Take as prescribed without skipping doses or stopping therapy","Rinse mouth after inhalation to reduce risk of candidiasis","Report signs of infection","Monitor glucose carefully if diabetic"]},
{"id":"rn-249","scope":["RN"],"name":{"generic":"Prednisone","brand":["Deltasone"]},"class":"Corticosteroid","mechanism":"Anti-inflammatory effects by stabilizing leukocyte lysosomal membranes, suppressing immune response, stimulating bone marrow activity, and affecting protein, fat, and carbohydrate metabolism","indications":["Asthmatic conditions","COPD"],"contraindications":["Hypersensitivity"],"interactions":["Antidiabetic drugs","NSAIDs","Cyclosporine"],"education":["Take as prescribed without skipping doses or stopping therapy","Do not stop abruptly","Report signs of infection","Monitor glucose carefully if diabetic"]},
{"id":"rn-250","scope":["RN"],"name":{"generic":"Methylprednisolone","brand":["Solumedrol"]},"class":"Corticosteroid","mechanism":"Anti-inflammatory effects by stabilizing leukocyte lysosomal membranes, suppressing immune response, stimulating bone marrow activity, and affecting protein, fat, and carbohydrate metabolism","indications":["Asthmatic conditions","COPD"],"contraindications":["Hypersensitivity"],"interactions":["Antidiabetic drugs","NSAIDs","Cyclosporine"],"education":["Take as prescribed without skipping doses or stopping therapy","Do not stop abruptly","Report signs of infection","Monitor glucose carefully if diabetic"]},
{"id":"rn-251","scope":["RN"],"name":{"generic":"Fluticasone","brand":["Flovent HFA"]},"class":"Corticosteroid","mechanism":"Anti-inflammatory effects by stabilizing leukocyte lysosomal membranes, suppressing immune response, stimulating bone marrow activity, and affecting protein, fat, and carbohydrate metabolism","indications":["Asthmatic conditions","COPD"],"contraindications":["Hypersensitivity"],"interactions":["Antidiabetic drugs","NSAIDs","Cyclosporine"],"education":["Take as prescribed without skipping doses or stopping therapy","Rinse mouth after inhalation to reduce risk of candidiasis","Report signs of infection","Monitor glucose carefully if diabetic"]},
{"id":"rn-252","scope":["RN"],"name":{"generic":"Budesonide","brand":["Pulmicort"]},"class":"Corticosteroid","mechanism":"Anti-inflammatory effects by stabilizing leukocyte lysosomal membranes, suppressing immune response, stimulating bone marrow activity, and affecting protein, fat, and carbohydrate metabolism","indications":["Asthmatic conditions","COPD"],"contraindications":["Hypersensitivity"],"interactions":["Antidiabetic drugs","NSAIDs","Cyclosporine"],"education":["Take as prescribed without skipping doses or stopping therapy","Rinse mouth after inhalation to reduce risk of candidiasis","Report signs of infection","Monitor glucose carefully if diabetic"]}

]
